Revised Medical Criteria for Evaluating Visual Disorders, 18837-18846 [2013-06975]
Download as PDF
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
155. From FERC’s Home Page on the
Internet, this information is available on
eLibrary. The full text of this document
is available on eLibrary in PDF and
Microsoft Word format for viewing,
printing, and/or downloading. To access
this document in eLibrary, type the
docket number excluding the last three
digits of this document in the docket
number field.
156. User assistance is available for
eLibrary and the FERC’s Web site during
normal business hours from FERC
Online Support at 202–502–6652 (toll
free at 1–866–208–3676) or email at
ferconlinesupport@ferc.gov, or the
Public Reference Room at (202) 502–
8371, TTY (202) 502–8659. Email the
Public Reference Room at
public.referenceroom@ferc.gov.
VII. Effective Date and Congressional
Notification
157. These regulations are effective
May 28, 2013. The Commission has
determined, with the concurrence of the
Administrator of the Office of
Information and Regulatory Affairs of
OMB, that this rule is not a ‘‘major rule’’
as defined in section 351 of the Small
Business Regulatory Enforcement
Fairness Act of 1996.
By the Commission.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
Note: The Appendix will not appear in the
Code of Federal Regulations.
srobinson on DSK4SPTVN1PROD with RULES
Appendix
Commenters
American Electric Power Service Corporation
(AEP)
Arizona Public Service Company (APS)
Bonneville Power Administration (BPA)
The City of Santa Clara, California, d/b/a
Silicon Valley Power (Santa Clara)
Duke Energy Corporation (Duke)
Electric Power Research Institute (EPRI)
FirstEnergy Service Company (FirstEnergy)
Idaho Power Company (Idaho Power)
International Transmission Company d/b/a/
ITCTransmission, Michigan Electric
Transmission Company, LLC, ITC Midwest
LLC and ITC Great Plains LLC (ITC
Companies)
Kansas City Power & Light Company and
KCP&L Greater Missouri Operations
Company, subsidiaries of Great Plains
Energy, Inc. (KCPL)
Manitoba Hydro
The New England States Committee on
Electricity (NESCOE)
North American Electric Reliability
Corporation (NERC)
Pacific Gas and Electric Company (PG&E)
PacifiCorp
The Pennsylvania Public Utility Commission
(PA PUC)
Southern Company Services, Inc., on behalf
of Alabama Power Company, Georgia
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
Power Company, Gulf Power Company,
and Mississippi Power Company (Southern
Companies)
Trade Associations (jointly, Edison Electric
Institute, American Public Power
Association, Large Public Power Council,
National Rural Electric Cooperative
Association, and Transmission Access
Policy Study Group)
Vermont Electric Power Company, Inc.
(VELCO)
Washington State Department of Natural
Resources (Washington DNR)
[FR Doc. 2013–07113 Filed 3–27–13; 8:45 am]
BILLING CODE 6717–01–P
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA–2010–0078]
RIN 0960–AH28
Revised Medical Criteria for Evaluating
Visual Disorders
Social Security Administration.
Final rules.
AGENCY:
ACTION:
SUMMARY: We are revising and
reorganizing the criteria in the Listing of
Impairments (listings) that we use to
evaluate cases involving visual
disorders in adults and children under
titles II and XVI of the Social Security
Act (Act). The revisions reflect our
program experience and guidance we
have issued in response to adjudicator
questions we have received since we
last revised these criteria in 2006. These
revisions will provide clarification
about how we evaluate visual disorders
and ensure more timely adjudication of
claims in which we evaluate visual
disorders that result in a loss of visual
acuity or field.
DATES: These rules are effective April
29, 2013.
FOR FURTHER INFORMATION CONTACT:
Cheryl A. Williams, Office of Medical
Listings Improvement, Social Security
Administration, 6401 Security
Boulevard, Baltimore, Maryland 21235–
6401, (410) 965–1020. For information
on eligibility or filing for benefits, call
our national toll-free number, 1–800–
772–1213 or TTY 1–800–325–0778, or
visit our Internet site, Social Security
Online, at https://
www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Background
We are making final the rules for
evaluating visual disorders we proposed
in a notice of proposed rulemaking
(NPRM) published in the Federal
Register on February 13, 2012 (77 FR
PO 00000
Frm 00043
Fmt 4700
Sfmt 4700
18837
7549). The preamble to the NPRM
provides a full explanation of the
background of these revisions. You can
view the preamble by visiting
www.regulations.gov and searching for
document ‘‘SSA–2010–0078–0001.’’ We
are making a number of changes because
of public comments to the NPRM. We
explain those changes in our summary
of the public comments and our
responses later in this preamble. We are
also making a number of minor editorial
changes throughout these final rules.
Why are we revising the listings for
evaluating visual disorders?
We are revising the listings for
evaluating visual disorders to update
the medical criteria, clarify how we
evaluate visual disorders, and address
adjudicator questions.
When will we begin to use these final
rules?
We will begin to use these final rules
on their effective date. We will continue
to use the current rules until the date
these final rules become effective. We
will apply the final rules to new
applications filed on or after the
effective date of these final rules and to
claims that are pending on or after the
effective date.1 These final rules will
remain in effect for 5 years after the date
they become effective, unless we extend
them, or revise and issue them again.
Public Comments
In the NPRM, we provided the public
with a 60-day comment period, which
ended on April 13, 2012. We received
12 public comment letters. The
comments came from members of the
public, national medical organizations,
disability examiners, and a national
association representing disability
examiners in the State agencies that
make disability determinations for us.
We have summarized the comments
below because some of them were long.
We summarized only those comments
with concerns or suggestions and
responded to the significant issues that
were relevant to this rulemaking. Some
commenters supported the proposed
changes and noted the provisions with
which they agreed. While we appreciate
those comments, we have not
summarized or responded to them
1 This means that we will use these final rules on
and after their effective date in any case in which
we make a determination or decision. We expect
that Federal courts will review our final decisions
using the rules that were in effect at the time we
issued the decisions. If a court reverses the
Commissioner’s final decision and remands a case
for further administrative proceedings after the
effective date of these final rules, we will apply
these final rules to the entire period at issue in the
decision we make after the court’s remand.
E:\FR\FM\28MRR1.SGM
28MRR1
18838
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
below because they do not require a
response.
srobinson on DSK4SPTVN1PROD with RULES
Evidence
Comment: One commenter suggested
that we replace the reference to
‘‘physician or optometrist’’ with
‘‘optometrist or ophthalmologist’’ in
2.00A4 and 102.00A4 where we explain
what evidence we need to evaluate
visual disorders, including those that
result in statutory blindness under title
II.
Response: We did not adopt this
comment because we removed the
reference to ‘‘physician or optometrist’’
from those sections. When we were
considering this comment, we
determined we did not need to include
the reference because our rules that
explain the sources who can provide
evidence to establish an impairment are
in 20 CFR 404.1513 and 416.913, and,
therefore, we do not need to restate
those sources in the introductory text.
Vision Testing
Comment: One commenter suggested
that we maintain the specific references
to the Humphrey Field Analyzer (HFA)
and Octopus perimeters that were
provided in the introductory text. The
commenter believed that the specific
references were essential for making
accurate determinations and decisions.
Response: We did not adopt this
comment because we believe that
providing the requirements for
acceptable perimeters and perimetry is
sufficient for accurate decisionmaking.
We provide the requirements for
acceptable perimeters in 2.00A9 and
102.00A9. We also provide the
requirements for acceptable perimetry
in 2.00A6 and 102.00A6 and include
examples of acceptable automated static
threshold tests (HFA 30–2, HFA 24–2,
and Octopus 32) that can be used to
evaluate visual field loss.
Comment: One commenter suggested
that we develop a formula for
determining the intensity of the
stimulus based on the maximum
stimulus luminance of the instrument
rather than include two examples in
2.00A6b(iii) and 102.00A6b(iii).
Response: We did not adopt the
commenter’s suggestion that we develop
a formula to determine the intensity of
the stimulus, but we did make a change
in the final rules to address the
commenter’s concern. We added a third
example (2.00Ab(iii)C and
102.00Ab(iii)C), so the listings now
include the most common maximum
stimulus luminances on automated
static threshold perimeters.
Comment: One commenter said that
the mean deviation in 2.03B and
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
102.03B varies by age and suggested that
we reconsider using mean deviation as
a listing criterion.
Response: We did not adopt this
comment. As we said when we
published the final rule in 2006 (71 FR
67013), the National Research Council
recommended that a mean deviation of
22 or worse on an automated static
threshold test measuring the central 30
degrees of the visual field would serve
as a reasonable criterion for disability
determination. We continue to agree
with that recommendation.2
Comment: One commenter requested
that we provide guidance on how to
interpret and assess medical findings
included in the case file that are outside
of the specified testing requirements.
Response: We did not adopt this
comment. We cannot provide guidance
on how to use all vision tests. We
believe that it is sufficient to provide
specific guidance on the testing that is
required to meet the listings. All other
testing found in the medical evidence
can be evaluated with the totality of the
evidence when making a determination
or decision at other steps in the
sequential evaluation.
Commenter: One commenter said that
our use of the term ‘‘cycloplegic
refraction’’ in proposed listing sections
2.00A5d and 102.00A5d is incorrect and
suggested that we revise the definition
for clarity and accuracy. The commenter
also noted that cycloplegic refraction is
a part of a comprehensive eye
examination and may be used to
provide a more precise measurement of
refractive error.
Response: We partially adopted this
comment. We revised the definition of
‘‘cycloplegic refraction’’ in 2.00A5d and
102.00A5d, but we did not adopt the
commenter’s suggestion to note that
cycloplegic refraction is a part of a
comprehensive eye examination. Rather,
we deleted the statement in the
proposed rules that said cycloplegic
refraction testing is not part of a routine
examination.
Evaluating Vision Loss in Young
Children
Comment: One commenter suggested
that we modify the behavioral criteria in
102.02B for evaluating visual acuity in
pre-verbal children by stating that the
inability to fixate and pursue a one-inch
toy at one foot with the better eye
qualifies as legal blindness in children
2 National
Research Council, Committee on
Disability Determination for Individuals with
Visual Impairments. (2002). Visual Impairments:
Determining Eligibility for Social Security Benefits.
Washington, DC: National Academy Press.
Retrieved from https://www.nap.edu/catalog/
10320.html?se_side.
PO 00000
Frm 00044
Fmt 4700
Sfmt 4700
over one year of age. Another
commenter suggested that we provide
additional guidance in 102.00A for
evaluating vision loss in young
children.
Response: We did not adopt these
comments. We believe that the guidance
we provide in 102.00A5a(iv) sufficiently
addresses the fact that very young
children test differently from older
children. We believe the requirements
of 102.02B adequately address the
possible issues that may arise when
testing very young children. There is no
need to modify the behavioral criteria.
We did, however, clarify in final
102.00A5a(iv) that the inability to
participate in testing using Snellen
methodology or other comparable
testing must be ‘‘due to your young
age.’’
Scotomas
Comment: One commenter suggested
that we expand our guidance on
scotomas in 2.00A6h by including
information about how scotomas affect
visual fields. The commenter also
suggested that we provide guidance on
the test instruments that would be best
for measuring and evaluating the
limitations caused by the scotoma.
Response: We did not adopt this
comment. We clarify the definition of
scotoma by including ‘‘field defect’’ in
addition to a ‘‘non-seeing area.’’ We
believe that the guidance we provide in
2.00A6h (and 102.00A6h) for how we
consider scotomas when evaluating
vision loss, in addition to the guidance
in 2.00A6a, 2.00A6b, and 2.00A6e (and
102.00A6a, 102.00A6b, and 102.00A6e)
on acceptable perimeters, explains
sufficiently how scotomas affect visual
fields, how we consider scotomas, and
which instruments are best for
measuring visual field loss.
Social Security Act
Comment: Several commenters
recommended that we amend the
language used in the Act regarding
blindness.
Response: We did not adopt these
comments. We use the language in the
Act in our regulations because we do
not have the authority to revise the
language Congress used in the Act
without Congressional legislation.
Visual Efficiency
Comment: One commenter noted that
the sum of the eight principal meridians
we identify in the right eye in Figure 1
in 2.00A7 is incorrect. The commenter
noted that the correct sum of the
principal meridians should be 530
instead of 500.
E:\FR\FM\28MRR1.SGM
28MRR1
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
srobinson on DSK4SPTVN1PROD with RULES
Response: We partially adopted this
comment. We revised Figure 1 in
2.00A7 and 102.00A7 to show the
points on the principal meridians
clearly. However, because we are using
the figure to explain a visual efficiency
percentage of 100 percent, the sum of
the meridians remains 500.
Comment: One commenter believed
that we should clarify our guidance on
visual efficiency values and percentages
to make it easier to differentiate between
the two. The commenter said that the
term ‘‘efficiency value’’ is inappropriate
because it indicates impairment rather
than severity, and the commenter
suggested that we use the term
‘‘impairment value.’’ The commenter
also believed that Table 1 in 2.00A7 is
confusing because it contains both
values and percentages.
Response: We adopted these
comments. We have revised 2.00A7 and
102.00A7, and added 2.00A8 and
102.00A8 to include language that
clarifies the differences between visual
acuity efficiency values and visual
acuity efficiency percentages. We also
revised the listing criteria for 2.04 and
102.04 to reflect the clarification.
Lenses
Comment: One commenter suggested
that we remove the phrase ‘‘because
they significantly reduce the visual
field’’ from our guidance on telescopic
lenses in 2.00A5c because reduced field
is only one of many reasons why
telescopic lenses should not be used to
test visual acuity.
Response: We adopted this comment.
We agree that there are several reasons
that the telescopic lens should not be
used to test visual acuity. It is
unnecessary to provide an explanation
for why each reason is unacceptable for
our purposes. We believe that it is
sufficient to simply state that visual
acuity measurements obtained with
telescopic lenses are unacceptable.
Comment: One commenter stated that
our use of ‘‘perimetric lenses’’ in
proposed 2.00A6g and 102.00A6g is
outdated because these types of lenses
are rarely used in modern medical
practice. The commenter believed that it
would be more logical to measure visual
fields using the person’s usual mode of
corrective lenses.
Response: We partially adopted this
comment. One of the goals of updating
our regulations is to address advances in
medical technology and terminology.
We have removed the term ‘‘perimetric
lenses’’ from 2.00A6g. We did not adopt
the comment about using the person’s
usual mode of corrective lenses for
testing. We continue to provide our
guidance that eyeglasses should not be
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
18839
worn during visual field testing. Visual
field testing accommodates the need for
eyeglasses or other corrective lenses,
allowing for accurate measurement of
visual fields.
PART 404—FEDERAL OLD–AGE,
SURVIVORS AND DISABILITY
INSURANCE (1950–)
What is our authority to make rules
and set procedures for determining
whether a person is disabled under the
statutory definition?
■
The Act authorizes us to make rules
and regulations and to establish
necessary and appropriate procedures to
implement them. Sections 205(a),
702(a)(5), and 1631(d)(1).
Executive Order 12866, as
Supplemented by Executive Order
13563
We have consulted with the Office of
Management and Budget (OMB) and
determined that these final rules meet
the criteria for a significant regulatory
action under Executive Order 12866, as
supplemented by Executive Order
13563. Therefore, OMB reviewed them.
Paperwork Reduction Act
These rules do not create any new or
affect any existing collections and,
therefore, do not require Office of
Management and Budget approval
under the Paperwork Reduction Act.
(Catalog of Federal Domestic Assistance
Program Nos. 96.001, Social Security—
Disability Insurance; 96.002, Social
Security—Retirement Insurance; 96.004,
Social Security—Survivors Insurance; and
96.006, Supplemental Security Income).
List of Subjects in 20 CFR Part 404
Administrative practice and
procedure; Blind, Disability benefits;
Old-Age, Survivors, and Disability
Insurance; Reporting and recordkeeping
requirements; Social Security.
Carolyn W. Colvin,
Acting Commissioner of Social Security.
For the reasons set out in the
preamble, we are amending 20 CFR
chapter III, part 404, subpart P as set
forth below:
Sfmt 4700
2. Amend appendix 1 to subpart P of
part 404 by:
■ a. Revising item 3 of the introductory
text before part A.
■ b. Revising section 2.00A in part A.
■ c. Revising sections 2.01 through 2.04
in part A.
■ d. Revising section 102.00A in part B.
■ e. Revising sections 102.101 through
102.104 in part B.
The revisions read as follows:
Appendix 1 to Subpart P of Part 404—
Listing of Impairments
*
*
*
*
3. Special Senses and Speech (2.00
and 102.00): April 29, 2018.
*
*
*
*
*
Part A
*
*
*
*
*
■
We certify that these final rules will
not have a significant economic impact
on a substantial number of small entities
because they affect individuals only.
Therefore, the Regulatory Flexibility
Act, as amended, does not require us to
prepare a regulatory flexibility analysis.
Fmt 4700
Authority: Secs. 202, 205(a)–(b) and (d)–
(h), 216(i), 221(a), (i), and (j), 222(c), 223,
225, and 702(a)(5) of the Social Security Act
(42 U.S.C. 402, 405(a)–(b) and (d)–(h), 416(i),
421(a), (i), and (j), 422(c), 423, 425, and
902(a)(5)); sec. 211(b), Pub. L. 104–193, 110
Stat. 2105, 2189; sec. 202, Pub. L. 108–203,
118 Stat. 509 (42 U.S.C. 902 note).
*
Regulatory Flexibility Act
Frm 00045
1. The authority citation for subpart P
of part 404 continues to read as follows:
■
Regulatory Procedures
PO 00000
Subpart P—[Amended]
2.00 SPECIAL SENSES AND SPEECH
A. How do we evaluate visual
disorders?
1. What are visual disorders? Visual
disorders are abnormalities of the eye,
the optic nerve, the optic tracts, or the
brain that may cause a loss of visual
acuity or visual fields. A loss of visual
acuity limits your ability to distinguish
detail, read, or do fine work. A loss of
visual fields limits your ability to
perceive visual stimuli in the peripheral
extent of vision.
2. How do we define statutory
blindness? Statutory blindness is
blindness as defined in sections
216(i)(1) and 1614(a)(2) of the Social
Security Act (Act).
a. The Act defines blindness as
central visual acuity of 20/200 or less in
the better eye with the use of a
correcting lens. We use your bestcorrected central visual acuity for
distance in the better eye when we
determine if this definition is met. (For
visual acuity testing requirements, see
2.00A5.)
b. The Act also provides that an eye
that has a visual field limitation such
that the widest diameter of the visual
field subtends an angle no greater than
20 degrees is considered as having a
E:\FR\FM\28MRR1.SGM
28MRR1
srobinson on DSK4SPTVN1PROD with RULES
18840
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
central visual acuity of 20/200 or less.
(For visual field testing requirements,
see 2.00A6.)
c. You have statutory blindness only
if your visual disorder meets the criteria
of 2.02 or 2.03A. You do not have
statutory blindness if your visual
disorder medically equals the criteria of
2.02 or 2.03A or meets or medically
equals the criteria of 2.03B, 2.03C,
2.04A, or 2.04B because your disability
is based on criteria other than those in
the statutory definition of blindness.
3. What evidence do we need to
establish statutory blindness under title
XVI? To establish that you have
statutory blindness under title XVI, we
need evidence showing only that your
central visual acuity in your better eye
or your visual field in your better eye
meets the criteria in 2.00A2, provided
that those measurements are consistent
with the other evidence in your case
record. We do not need documentation
of the cause of your blindness. Also,
there is no duration requirement for
statutory blindness under title XVI (see
§§ 416.981 and 416.983 of this chapter).
4. What evidence do we need to
evaluate visual disorders, including
those that result in statutory blindness
under title II? To evaluate your visual
disorder, we usually need a report of an
eye examination that includes
measurements of your best-corrected
central visual acuity (see 2.00A5) or the
extent of your visual fields (see 2.00A6),
as appropriate. If you have visual acuity
or visual field loss, we need
documentation of the cause of the loss.
A standard eye examination will usually
indicate the cause of any visual acuity
loss. A standard eye examination can
also indicate the cause of some types of
visual field deficits. Some disorders,
such as cortical visual disorders, may
result in abnormalities that do not
appear on a standard eye examination.
If the standard eye examination does not
indicate the cause of your vision loss,
we will request the information used to
establish the presence of your visual
disorder. If your visual disorder does
not satisfy the criteria in 2.02, 2.03, or
2.04, we will request a description of
how your visual disorder affects your
ability to function.
5. How do we measure your bestcorrected central visual acuity?
a. Visual acuity testing. When we
need to measure your best-corrected
central visual acuity (your optimal
visual acuity attainable with the use of
a corrective lens), we use visual acuity
testing for distance that was carried out
using Snellen methodology or any other
testing methodology that is comparable
to Snellen methodology.
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
(i) Your best-corrected central visual
acuity for distance is usually measured
by determining what you can see from
20 feet. If your visual acuity is measured
for a distance other than 20 feet, we will
convert it to a 20-foot measurement. For
example, if your visual acuity is
measured at 10 feet and is reported as
10/40, we will convert this
measurement to 20/80.
(ii) A visual acuity recorded as CF
(counts fingers), HM (hand motion
only), LP or LPO (light perception or
light perception only), or NLP (no light
perception) indicates that no optical
correction will improve your visual
acuity. If your central visual acuity in an
eye is recorded as CF, HM, LP or LPO,
or NLP, we will determine that your
best-corrected central visual acuity is
20/200 or less in that eye.
(iii) We will not use the results of
pinhole testing or automated refraction
acuity to determine your best-corrected
central visual acuity. These tests
provide an estimate of potential visual
acuity but not an actual measurement of
your best-corrected central visual
acuity.
b. Other test charts. Most test charts
that use Snellen methodology do not
have lines that measure visual acuity
between 20/100 and 20/200. Some test
charts, such as the Bailey-Lovie or the
Early Treatment Diabetic Retinopathy
Study (ETDRS), used mostly in research
settings, have such lines. If your visual
acuity is measured with one of these
charts, and you cannot read any of the
letters on the 20/100 line, we will
determine that you have statutory
blindness based on a visual acuity of 20/
200 or less. For example, if your bestcorrected central visual acuity for
distance in the better eye is 20/160
using an ETDRS chart, we will find that
you have statutory blindness. Regardless
of the type of test chart used, you do not
have statutory blindness if you can read
at least one letter on the 20/100 line. For
example, if your best-corrected central
visual acuity for distance in the better
eye is 20/125+1 using an ETDRS chart,
we will find that you do not have
statutory blindness because you are able
to read one letter on the 20/100 line.
c. Testing using a specialized lens. In
some instances, you may have visual
acuity testing performed using
specialized lens, such as a contact lens.
We will use the visual acuity
measurements obtained with a
specialized lens only if you have
demonstrated the ability to use the
specialized lens on a sustained basis.
We will not use visual acuity
measurements obtained with telescopic
lenses.
PO 00000
Frm 00046
Fmt 4700
Sfmt 4700
d. Cycloplegic refraction is an
examination of the eye performed after
administering cycloplegic eye drops
capable of relaxing the ability of the
pupil to become smaller and
temporarily paralyzing the focusing
muscles. If your case record contains the
results of cycloplegic refraction, we may
use the results to determine your bestcorrected central visual acuity. We will
not purchase cycloplegic refraction.
e. Visual evoked response (VER)
testing measures your response to visual
events and can often detect dysfunction
that is undetectable through other types
of examinations. If you have an absent
response to VER testing in your better
eye, we will determine that your bestcorrected central visual acuity is 20/200
or less in that eye and that your visual
acuity loss satisfies the criterion in 2.02
when these test results are consistent
with the other evidence in your case
record. If you have a positive response
to VER testing in an eye, we will not use
that result to determine your bestcorrected central visual acuity in that
eye.
6. How do we measure your visual
fields?
a. General. We generally need visual
field testing when you have a visual
disorder that could result in visual field
loss, such as glaucoma, retinitis
pigmentosa, or optic neuropathy, or
when you display behaviors that suggest
a visual field loss. When we need to
measure the extent of your visual field
loss, we use visual field testing (also
referred to as perimetry) carried out
using automated static threshold
perimetry performed on an acceptable
perimeter. (For perimeter requirements,
see 2.00A9.)
b. Automated static threshold
perimetry requirements.
(i) The test must use a white size III
Goldmann stimulus and a 31.5 apostilb
(asb) white background (or a 10 candela
per square meter (cd/m2) white
background). The stimuli test locations
must be no more than 6 degrees apart
horizontally or vertically. Measurements
must be reported on standard charts and
include a description of the size and
intensity of the test stimulus.
(ii) We measure the extent of your
visual field loss by determining the
portion of the visual field in which you
can see a white III4e stimulus. The ‘‘III’’
refers to the standard Goldmann test
stimulus size III (4 mm2), and the ‘‘4e’’
refers to the standard Goldmann
intensity filter (0 decibel (dB)
attenuation, which allows presentation
of the maximum luminance) used to
determine the intensity of the stimulus.
(iii) In automated static threshold
perimetry, the intensity of the stimulus
E:\FR\FM\28MRR1.SGM
28MRR1
srobinson on DSK4SPTVN1PROD with RULES
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
varies. The intensity of the stimulus is
expressed in decibels (dB). A
perimeter’s maximum stimulus
luminance is usually assigned the value
0 dB. We need to determine the dB level
that corresponds to a 4e intensity for the
particular perimeter being used. We will
then use the dB printout to determine
which points you see at a 4e intensity
level (a ‘‘seeing point’’). For example:
A. When the maximum stimulus
luminance (0 dB stimulus) on an
acceptable perimeter is 10,000 asb, a 10
dB stimulus is equivalent to a 4e
stimulus. Any point you see at 10 dB or
greater is a seeing point.
B. When the maximum stimulus
luminance (0 dB stimulus) on an
acceptable perimeter is 4,000 asb, a 6 dB
stimulus is equivalent to a 4e stimulus.
Any point you see at 6 dB or greater is
a seeing point.
C. When the maximum stimulus
luminance (0 dB stimulus) on an
acceptable perimeter is 1,000 asb, a 0 dB
stimulus is equivalent to a 4e stimulus.
Any point you see at 0 dB or greater is
a seeing point.
c. Evaluation under 2.03A. To
determine statutory blindness based on
visual field loss in your better eye
(2.03A), we need the results of a visual
field test that measures the central 24 to
30 degrees of your visual field; that is,
the area measuring 24 to 30 degrees
from the point of fixation. Acceptable
tests include the Humphrey Field
Analyzer (HFA) 30–2, HFA 24–2, and
Octopus 32.
d. Evaluation under 2.03B. To
determine whether your visual field loss
meets listing 2.03B, we use the mean
deviation or defect (MD) from
acceptable automated static threshold
perimetry that measures the central 30
degrees of the visual field. MD is the
average sensitivity deviation from
normal values for all measured visual
field locations. When using results from
HFA tests, which report the MD as a
negative number, we use the absolute
value of the MD to determine whether
your visual field loss meets listing
2.03B. We cannot use tests that do not
measure the central 30 degrees of the
visual field, such as the HFA 24–2, to
determine if your impairment meets or
medically equals 2.03B.
e. Other types of perimetry. If the
evidence in your case contains visual
field measurements obtained using
manual or automated kinetic perimetry,
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
such as Goldmann perimetry or the HFA
‘‘SSA Test Kinetic,’’ we can generally
use these results if the kinetic test was
performed using a white III4e stimulus
projected on a white 31.5 asb (10 cd/m2)
background. Automated kinetic
perimetry, such as the HFA ‘‘SSA Test
Kinetic,’’ does not detect limitations in
the central visual field because testing
along a meridian stops when you see the
stimulus. If your visual disorder has
progressed to the point at which it is
likely to result in a significant limitation
in the central visual field, such as a
scotoma (see 2.00A6h), we will not use
automated kinetic perimetry to
determine the extent of your visual field
loss. Instead, we will determine the
extent of your visual field loss using
automated static threshold perimetry or
manual kinetic perimetry.
f. Screening tests. We will not use the
results of visual field screening tests,
such as confrontation tests, tangent
screen tests, or automated static
screening tests, to determine that your
impairment meets or medically equals a
listing or to evaluate your residual
functional capacity. We can consider
normal results from visual field
screening tests to determine whether
your visual disorder is severe when
these test results are consistent with the
other evidence in your case record. (See
§§ 404.1520(c), 404.1521, 416.920(c),
and 416.921 of this chapter.) We will
not consider normal test results to be
consistent with the other evidence if the
clinical findings indicate that your
visual disorder has progressed to the
point that it is likely to cause visual
field loss, or you have a history of an
operative procedure for retinal
detachment.
g. Use of corrective lenses. You must
not wear eyeglasses during visual field
testing because they limit your field of
vision. You may wear contact lenses to
correct your visual acuity during the
visual field test to obtain the most
accurate visual field measurements. For
this single purpose, you do not need to
demonstrate that you have the ability to
use the contact lenses on a sustained
basis.
h. Scotoma. A scotoma is a field
defect or non-seeing area (also referred
to as a ‘‘blind spot’’) in the visual field
surrounded by a normal field or seeing
area. When we measure your visual
field, we subtract the length of any
scotoma, other than the normal blind
PO 00000
Frm 00047
Fmt 4700
Sfmt 4700
18841
spot, from the overall length of any
diameter on which it falls.
7. How do we determine your visual
acuity efficiency, visual field efficiency,
and visual efficiency?
a. General. Visual efficiency, a
calculated value of your remaining
visual function, is the combination of
your visual acuity efficiency and your
visual field efficiency expressed as a
percentage.
b. Visual acuity efficiency. Visual
acuity efficiency is a percentage that
corresponds to the best-corrected central
visual acuity for distance in your better
eye. See Table 1.
TABLE 1—VISUAL ACUITY EFFICIENCY
Snellen best-corrected central
visual acuity for distance
English
Metric
Visual acuity
efficiency (%)
(2.04A)
20/16
20/20
20/25
20/30
20/40
20/50
20/60
20/70
20/80
20/100
6/5
6/6
6/7.5
6/9
6/12
6/15
6/18
6/21
6/24
6/30
100
100
95
90
85
75
70
65
60
50
c. Visual field efficiency. Visual field
efficiency is a percentage that
corresponds to the visual field in your
better eye. Under 2.03C, we require
kinetic perimetry to determine your
visual field efficiency percentage. We
calculate the visual field efficiency
percentage by adding the number of
degrees you see along the eight
principal meridians found on a visual
field chart (0, 45, 90, 135, 180, 225, 270,
and 315) in your better eye and dividing
by 5. For example, in Figure 1:
A. The diagram of the left eye
illustrates a visual field, as measured
with a III4e stimulus, contracted to 30
degrees in two meridians (180 and 225)
and to 20 degrees in the remaining six
meridians. The visual efficiency
percentage of this field is: ((2 × 30) + (6
× 20)) ÷ 5 = 36 percent.
B. The diagram of the right eye
illustrates the extent of a normal visual
field as measured with a III4e stimulus.
The sum of the eight principal
meridians of this field is 500 degrees.
The visual efficiency percentage of this
field is 500 ÷ 5 = 100 percent.
E:\FR\FM\28MRR1.SGM
28MRR1
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
d. Visual efficiency. Under 2.04A, we
calculate the visual efficiency
percentage by multiplying your visual
acuity efficiency percentage (see
2.00A7b) by your visual field efficiency
percentage (see 2.00A7c) and dividing
by 100. For example, if your visual
acuity efficiency percentage is 75 and
your visual field efficiency percentage is
36, your visual efficiency percentage is:
(75 × 36) ÷ 100 = 27 percent.
8. How do we determine your visual
acuity impairment value, visual field
impairment value, and visual
impairment value?
a. General. Visual impairment value,
a calculated value of your loss of visual
function, is the combination of your
visual acuity impairment value and
your visual field impairment value.
b. Visual acuity impairment value.
Your visual acuity impairment value
corresponds to the best-corrected central
visual acuity for distance in your better
eye. See Table 2.
srobinson on DSK4SPTVN1PROD with RULES
TABLE 2—VISUAL ACUITY IMPAIRMENT
VALUE
Snellen best-corrected central
visual acuity for distance
English
Metric
20/16
20/20
20/25
20/30
6/5
6/6
6/7.5
6/9
Visual acuity
impairment
value (2.04B)
VerDate Mar<15>2010
19:56 Mar 27, 2013
0.00
0.00
0.10
0.18
Jkt 229001
TABLE 2—VISUAL ACUITY IMPAIRMENT
VALUE—Continued
Snellen best-corrected central
visual acuity for distance
20/40
20/50
20/60
20/70
20/80
20/100
6/12
6/15
6/18
6/21
6/24
6/30
0.30
0.40
0.48
0.54
0.60
0.70
c. Visual field impairment value. Your
visual field impairment value
corresponds to the visual field in your
better eye. Using the MD from
acceptable automated static threshold
perimetry, we calculate the visual field
impairment value by dividing the
absolute value of the MD by 22. For
example, if your MD on an HFA 30–2
is ¥16, your visual field impairment
value is: ¥16√ ÷ 22 = 0.73.
d. Visual impairment value. Under
2.04B, we calculate the visual
impairment value by adding your visual
acuity impairment value (see 2.00A8b)
and your visual field impairment value
(see 2.00A8c). For example, if your
visual acuity impairment value is 0.48
and your visual field impairment value
is 0.73, your visual impairment value is:
0.48 + 0.73 = 1.21.
9. What are our requirements for an
acceptable perimeter? We will use
results from automated static threshold
PO 00000
Frm 00048
Fmt 4700
Sfmt 4700
perimetry performed on a perimeter
that:
a. Uses optical projection to generate
the test stimuli.
b. Has an internal normative database
for automatically comparing your
performance with that of the general
population.
c. Has a statistical analysis package
that is able to calculate visual field
indices, particularly MD.
d. Demonstrates the ability to
correctly detect visual field loss and
correctly identify normal visual fields.
e. Demonstrates good test-retest
reliability.
f. Has undergone clinical validation
studies by three or more independent
laboratories with results published in
peer-reviewed ophthalmic journals.
*
*
*
*
*
2.01 Category of Impairments,
Special Senses and Speech
2.02 Loss of central visual acuity.
Remaining vision in the better eye after
best correction is 20/200 or less.
2.03 Contraction of the visual field
in the better eye, with:
A. The widest diameter subtending an
angle around the point of fixation no
greater than 20 degrees.
OR
B. An MD of 22 decibels or greater,
determined by automated static
threshold perimetry that measures the
central 30 degrees of the visual field (see
2.00A6d).
OR
E:\FR\FM\28MRR1.SGM
28MRR1
ER28MR13.002
18842
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
C. A visual field efficiency of 20
percent or less, determined by kinetic
perimetry (see 2.00A7c).
2.04 Loss of visual efficiency, or
visual impairment, in the better eye:
A. A visual efficiency percentage of
20 or less after best correction (see
2.00A7d).
OR
B. A visual impairment value of 1.00
or greater after best correction (see
2.00A8d).
*
*
*
*
*
Part B
*
*
*
*
*
srobinson on DSK4SPTVN1PROD with RULES
102.00 SPECIAL SENSES AND
SPEECH
A. How do we evaluate visual
disorders?
1. What are visual disorders? Visual
disorders are abnormalities of the eye,
the optic nerve, the optic tracts, or the
brain that may cause a loss of visual
acuity or visual fields. A loss of visual
acuity limits your ability to distinguish
detail, read, do fine work, or perform
other age-appropriate activities. A loss
of visual fields limits your ability to
perceive visual stimuli in the peripheral
extent of vision.
2. How do we define statutory
blindness? Statutory blindness is
blindness as defined in sections
216(i)(1) and 1614(a)(2) of the Social
Security Act (Act).
a. The Act defines blindness as
central visual acuity of 20/200 or less in
the better eye with the use of a
correcting lens. We use your bestcorrected central visual acuity for
distance in the better eye when we
determine if this definition is met. (For
visual acuity testing requirements, see
102.00A5.)
b. The Act also provides that an eye
that has a visual field limitation such
that the widest diameter of the visual
field subtends an angle no greater than
20 degrees is considered as having a
central visual acuity of 20/200 or less.
(For visual field testing requirements,
see 102.00A6.)
c. You have statutory blindness only
if your visual disorder meets the criteria
of 102.02A, 102.02B, or 102.03A. You
do not have statutory blindness if your
visual disorder medically equals the
criteria of 102.02A, 102.02B, or 102.03A
or meets or medically equals the criteria
of 102.03B, 102.03C, 102.04A, or
102.04B because your disability is based
on criteria other than those in the
statutory definition of blindness.
3. What evidence do we need to
establish statutory blindness under title
XVI? To establish that you have
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
statutory blindness under title XVI, we
need evidence showing only that your
central visual acuity in your better eye
or your visual field in your better eye
meets the criteria in 102.00A2, provided
that those measurements are consistent
with the other evidence in your case
record. We do not need documentation
of the cause of your blindness. Also,
there is no duration requirement for
statutory blindness under title XVI (see
§§ 416.981 and 416.983 of this chapter).
4. What evidence do we need to
evaluate visual disorders, including
those that result in statutory blindness
under title II? To evaluate your visual
disorder, we usually need a report of an
eye examination that includes
measurements of your best-corrected
central visual acuity (see 102.00A5) or
the extent of your visual fields (see
102.00A6), as appropriate. If you have
visual acuity or visual field loss, we
need documentation of the cause of the
loss. A standard eye examination will
usually indicate the cause of any visual
acuity loss. A standard eye examination
can also indicate the cause of some
types of visual field deficits. Some
disorders, such as cortical visual
disorders, may result in abnormalities
that do not appear on a standard eye
examination. If the standard eye
examination does not indicate the cause
of your vision loss, we will request the
information used to establish the
presence of your visual disorder. If your
visual disorder does not satisfy the
criteria in 102.02, 102.03, or 102.04, we
will request a description of how your
visual disorder affects your ability to
function.
5. How do we measure your bestcorrected central visual acuity?
a. Visual acuity testing. When we
need to measure your best-corrected
central visual acuity, which is your
optimal visual acuity attainable with the
use of a corrective lens, we use visual
acuity testing for distance that was
carried out using Snellen methodology
or any other testing methodology that is
comparable to Snellen methodology.
(i) Your best-corrected central visual
acuity for distance is usually measured
by determining what you can see from
20 feet. If your visual acuity is measured
for a distance other than 20 feet, we will
convert it to a 20-foot measurement. For
example, if your visual acuity is
measured at 10 feet and is reported as
10/40, we will convert this
measurement to 20/80.
(ii) A visual acuity recorded as CF
(counts fingers), HM (hand motion
only), LP or LPO (light perception or
light perception only), or NLP (no light
perception) indicates that no optical
correction will improve your visual
PO 00000
Frm 00049
Fmt 4700
Sfmt 4700
18843
acuity. If your central visual acuity in an
eye is recorded as CF, HM, LP or LPO,
or NLP, we will determine that your
best-corrected central visual acuity is
20/200 or less in that eye.
(iii) We will not use the results of
pinhole testing or automated refraction
acuity to determine your best-corrected
central visual acuity. These tests
provide an estimate of potential visual
acuity but not an actual measurement of
your best-corrected central visual
acuity.
(iv) Very young children, such as
infants and toddlers, cannot participate
in testing using Snellen methodology or
other comparable testing. If you are
unable to participate in testing using
Snellen methodology or other
comparable testing due to your young
age, we will consider clinical findings of
your fixation and visual-following
behavior. If both these behaviors are
absent, we will consider the anatomical
findings or the results of neuroimaging,
electroretinogram, or visual evoked
response (VER) testing when this testing
has been performed.
b. Other test charts.
(i) Children between the ages of 3 and
5 often cannot identify the letters on a
Snellen or other letter test chart.
Specialists with expertise in assessment
of childhood vision use alternate
methods for measuring visual acuity in
young children. We consider alternate
methods, for example, the Landolt C test
or the tumbling-E test, which are used
to evaluate young children who are
unable to participate in testing using
Snellen methodology, to be comparable
to testing using Snellen methodology.
(ii) Most test charts that use Snellen
methodology do not have lines that
measure visual acuity between 20/100
and 20/200. Some test charts, such as
the Bailey-Lovie or the Early Treatment
Diabetic Retinopathy Study (ETDRS),
used mostly in research settings, have
such lines. If your visual acuity is
measured with one of these charts, and
you cannot read any of the letters on the
20/100 line, we will determine that you
have statutory blindness based on a
visual acuity of 20/200 or less. For
example, if your best-corrected central
visual acuity for distance in the better
eye is 20/160 using an ETDRS chart, we
will find that you have statutory
blindness. Regardless of the type of test
chart used, you do not have statutory
blindness if you can read at least one
letter on the 20/100 line. For example,
if your best-corrected central visual
acuity for distance in the better eye is
20/125+1 using an ETDRS chart, we will
find that you do not have statutory
blindness because you are able to read
one letter on the 20/100 line.
E:\FR\FM\28MRR1.SGM
28MRR1
srobinson on DSK4SPTVN1PROD with RULES
18844
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
c. Testing using a specialized lens. In
some instances, you may have visual
acuity testing performed using a
specialized lens, such as a contact lens.
We will use the visual acuity
measurements obtained with a
specialized lens only if you have
demonstrated the ability to use the
specialized lens on a sustained basis.
We will not use visual acuity
measurements obtained with telescopic
lenses.
d. Cycloplegic refraction is an
examination of the eye performed after
administering cycloplegic eye drops
capable of relaxing the ability of the
pupil to become smaller and
temporarily paralyzing the focusing
muscles. If your case record contains the
results of cycloplegic refraction, we may
use the results to determine your bestcorrected central visual acuity. We will
not purchase cycloplegic refraction.
e. VER testing measures your response
to visual events and can often detect
dysfunction that is undetectable through
other types of examinations. If you have
an absent response to VER testing in
your better eye, we will determine that
your best-corrected central visual acuity
is 20/200 or less in that eye and that
your visual acuity loss satisfies the
criterion in 102.02A or 102.02B4, as
appropriate, when these test results are
consistent with the other evidence in
your case record. If you have a positive
response to VER testing in an eye, we
will not use that result to determine
your best-corrected central visual acuity
in that eye.
6. How do we measure your visual
fields?
a. General. We generally need visual
field testing when you have a visual
disorder that could result in visual field
loss, such as glaucoma, retinitis
pigmentosa, or optic neuropathy, or
when you display behaviors that suggest
a visual field loss. When we need to
measure the extent of your visual field
loss, we use visual field testing (also
referred to as perimetry) carried out
using automated static threshold
perimetry performed on an acceptable
perimeter. (For perimeter requirements,
see 102.00A9.)
b. Automated static threshold
perimetry requirements.
(i) The test must use a white size III
Goldmann stimulus and a 31.5 apostilb
(asb) white background (or a 10 candela
per square meter (cd/m2) white
background). The stimuli test locations
must be no more than 6 degrees apart
horizontally or vertically. Measurements
must be reported on standard charts and
include a description of the size and
intensity of the test stimulus.
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
(ii) We measure the extent of your
visual field loss by determining the
portion of the visual field in which you
can see a white III4e stimulus. The ‘‘III’’
refers to the standard Goldmann test
stimulus size III (4 mm2), and the ‘‘4e’’
refers to the standard Goldmann
intensity filter (0 decibel (dB)
attenuation, which allows presentation
of the maximum luminance) used to
determine the intensity of the stimulus.
(iii) In automated static threshold
perimetry, the intensity of the stimulus
varies. The intensity of the stimulus is
expressed in decibels (dB). A
perimeter’s maximum stimulus
luminance is usually assigned the value
0 dB. We need to determine the dB level
that corresponds to a 4e intensity for the
particular perimeter being used. We will
then use the dB printout to determine
which points you see at a 4e intensity
level (a ‘‘seeing point’’). For example:
A. When the maximum stimulus
luminance (0 dB stimulus) on an
acceptable perimeter is 10,000 asb, a 10
dB stimulus is equivalent to a 4e
stimulus. Any point you see at 10 dB or
greater is a seeing point.
B. When the maximum stimulus
luminance (0 dB stimulus) on an
acceptable perimeter is 4,000 asb, a 6 dB
stimulus is equivalent to a 4e stimulus.
Any point you see at 6 dB or greater is
a seeing point.
C. When the maximum stimulus
luminance (0 dB stimulus) on an
acceptable perimeter is 1,000 asb, a 0 dB
stimulus is equivalent to a 4e stimulus.
Any point you see at 0 dB or greater is
a seeing point.
c. Evaluation under 102.03A. To
determine statutory blindness based on
visual field loss in your better eye
(102.03A), we need the results of a
visual field test that measures the
central 24 to 30 degrees of your visual
field; that is, the area measuring 24 to
30 degrees from the point of fixation.
Acceptable tests include the Humphrey
Field Analyzer (HFA) 30–2, HFA 24–2,
and Octopus 32.
d. Evaluation under 102.03B. To
determine whether your visual field loss
meets listing 102.03B, we use the mean
deviation or defect (MD) from
acceptable automated static threshold
perimetry that measures the central 30
degrees of the visual field. MD is the
average sensitivity deviation from
normal values for all measured visual
field locations. When using results from
HFA tests, which report the MD as a
negative number, we use the absolute
value of the MD to determine whether
your visual field loss meets listing
102.03B. We cannot use tests that do not
measure the central 30 degrees of the
visual field, such as the HFA 24–2, to
PO 00000
Frm 00050
Fmt 4700
Sfmt 4700
determine if your impairment meets or
medically equals 102.03B.
e. Other types of perimetry. If your
case record contains visual field
measurements obtained using manual or
automated kinetic perimetry, such as
Goldmann perimetry or the HFA ‘‘SSA
Test Kinetic,’’ we can generally use
these results if the kinetic test was
performed using a white III4e stimulus
projected on a white 31.5 asb (10 cd/m2)
background. Automated kinetic
perimetry, such as the HFA ‘‘SSA Test
Kinetic,’’ does not detect limitations in
the central visual field because testing
along a meridian stops when you see the
stimulus. If your visual disorder has
progressed to the point at which it is
likely to result in a significant limitation
in the central visual field, such as a
scotoma (see 102.00A6h), we will not
use automated kinetic perimetry to
determine the extent of your visual field
loss. Instead, we will determine the
extent of your visual field loss using
automated static threshold perimetry or
manual kinetic perimetry.
f. Screening tests. We will not use the
results of visual field screening tests,
such as confrontation tests, tangent
screen tests, or automated static
screening tests, to determine that your
impairment meets or medically equals a
listing, or functionally equals the
listings. We can consider normal results
from visual field screening tests to
determine whether your visual disorder
is severe when these test results are
consistent with the other evidence in
your case record. (See § 416.924(c) of
this chapter.) We will not consider
normal test results to be consistent with
the other evidence if the clinical
findings indicate that your visual
disorder has progressed to the point that
it is likely to cause visual field loss, or
you have a history of an operative
procedure for retinal detachment.
g. Use of corrective lenses. You must
not wear eyeglasses during visual field
testing because they limit your field of
vision. You may wear contact lenses to
correct your visual acuity during the
visual field test to obtain the most
accurate visual field measurements. For
this single purpose, you do not need to
demonstrate that you have the ability to
use the contact lenses on a sustained
basis.
h. Scotoma. A scotoma is a field
defect or non-seeing area (also referred
to as a ‘‘blind spot’’) in the visual field
surrounded by a normal field or seeing
area. When we measure your visual
field, we subtract the length of any
scotoma, other than the normal blind
spot, from the overall length of any
diameter on which it falls.
E:\FR\FM\28MRR1.SGM
28MRR1
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
TABLE 1—VISUAL ACUITY
EFFICIENCY—Continued
Snellen best-corrected central
visual acuity for distance
English
20/20
20/25
20/30
20/40
20/50
20/60
20/70
20/80
20/100
TABLE 1—VISUAL ACUITY EFFICIENCY
Snellen best-corrected central
visual acuity for distance
Metric
20/16
srobinson on DSK4SPTVN1PROD with RULES
English
Visual acuity
efficiency (%)
(102.04A)
6/5
100
d. Visual efficiency. Under 102.04A,
we calculate the visual efficiency
percentage by multiplying your visual
acuity efficiency percentage (see
102.00A7b) by your visual field
efficiency percentage (see 102.00A7c)
and dividing by 100. For example, if
your visual acuity efficiency percentage
is 75 and your visual field efficiency
percentage is 36, your visual efficiency
percentage is: (75 × 36) ÷ 100 = 27
percent.
8. How do we determine your visual
acuity impairment value, visual field
VerDate Mar<15>2010
17:43 Mar 27, 2013
Jkt 229001
Metric
Visual acuity
efficiency (%)
(102.04A)
6/6
6/7.5
6/9
6/12
6/15
6/18
6/21
6/24
6/30
100
95
90
85
75
70
65
60
50
c. Visual field efficiency. Visual field
efficiency is a percentage that
corresponds to the visual field in your
better eye. Under 102.03C, we require
kinetic perimetry to determine your
visual field efficiency percentage. We
impairment value, and visual
impairment value?
a. General. Visual impairment value,
a calculated value of your loss of visual
function, is the combination of your
visual acuity impairment value and
your visual field impairment value.
b. Visual acuity impairment value.
Your visual acuity impairment value
corresponds to the best-corrected central
visual acuity for distance in your better
eye. See Table 2.
PO 00000
Frm 00051
Fmt 4700
Sfmt 4700
calculate the visual field efficiency
percentage by adding the number of
degrees you see along the eight
principal meridians found on a visual
field chart (0, 45, 90, 135, 180, 225, 270,
and 315) in your better eye and dividing
by 5. For example, in Figure 1:
A. The diagram of the left eye
illustrates a visual field, as measured
with a III4e stimulus, contracted to 30
degrees in two meridians (180 and 225)
and to 20 degrees in the remaining six
meridians. The visual efficiency
percentage of this field is: ((2 × 30) + (6
× 20)) ÷ 5 = 36 percent.
B. The diagram of the right eye
illustrates the extent of a normal visual
field as measured with a III4e stimulus.
The sum of the eight principal
meridians of this field is 500 degrees.
The visual efficiency percentage of this
field is 500 ÷ 5 = 100 percent.
TABLE 2—VISUAL ACUITY IMPAIRMENT
VALUE
Snellen best-corrected central
visual acuity for distance
English
Metric
Visual acuity
impairment
value
(102.04B)
20/16
20/20
20/25
20/30
20/40
20/50
20/60
20/70
6/5
6/6
6/7.5
6/9
6/12
6/15
6/18
6/21
0.00
0.00
0.10
0.18
0.30
0.40
0.48
0.54
E:\FR\FM\28MRR1.SGM
28MRR1
ER28MR13.003
7. How do we determine your visual
acuity efficiency, visual field efficiency,
and visual efficiency?
a. General. Visual efficiency, a
calculated value of your remaining
visual function, is the combination of
your visual acuity efficiency and your
visual field efficiency expressed as a
percentage.
b. Visual acuity efficiency. Visual
acuity efficiency is a percentage that
corresponds to the best-corrected central
visual acuity for distance in your better
eye. See Table 1.
18845
18846
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Rules and Regulations
TABLE 2—VISUAL ACUITY IMPAIRMENT
VALUE—Continued
Snellen best-corrected central
visual acuity for distance
English
Metric
Visual acuity
impairment
value
(102.04B)
20/80
20/100
6/24
6/30
0.60
0.70
c. Visual field impairment value. Your
visual field impairment value
corresponds to the visual field in your
better eye. Using the MD from
acceptable automated static threshold
perimetry, we calculate the visual field
impairment value by dividing the
absolute value of the MD by 22. For
example, if your MD on an HFA 30–2
is ¥16, your visual field impairment
value is: |¥16| ÷ 22 = 0.73.
d. Visual impairment value. Under
102.04B, we calculate the visual
impairment value by adding your visual
acuity impairment value (see
102.00A8b) and your visual field
impairment value (see 102.00A8c). For
example, if your visual acuity
impairment value is 0.48 and your
visual field impairment value is 0.73,
your visual impairment value is: 0.48 +
0.73 = 1.21.
9. What are our requirements for an
acceptable perimeter? We will use
results from automated static threshold
perimetry performed on a perimeter
that:
a. Uses optical projection to generate
the test stimuli.
b. Has an internal normative database
for automatically comparing your
performance with that of the general
population.
c. Has a statistical analysis package
that is able to calculate visual field
indices, particularly mean deviation or
mean defect.
d. Demonstrates the ability to
correctly detect visual field loss and
correctly identify normal visual fields.
e. Demonstrates good test-retest
reliability.
f. Has undergone clinical validation
studies by three or more independent
laboratories with results published in
peer-reviewed ophthalmic journals.
*
*
*
*
*
srobinson on DSK4SPTVN1PROD with RULES
102.01 Category of Impairments,
Special Senses and Speech
17:43 Mar 27, 2013
Jkt 229001
[FR Doc. 2013–06975 Filed 3–27–13; 8:45 am]
BILLING CODE 4191–02–P
DEPARTMENT OF DEFENSE
Department of the Navy
32 CFR Part 706
102.02 Loss of central visual acuity.
A. Remaining vision in the better eye
after best correction is 20/200 or less.
OR
B. An inability to participate in visual
acuity testing using Snellen
methodology or other comparable
testing, clinical findings that fixation
VerDate Mar<15>2010
and visual-following behavior are absent
in the better eye, and one of the
following:
1. Abnormal anatomical findings
indicating a visual acuity of 20/200 or
less in the better eye (such as the
presence of Stage III or worse
retinopathy of prematurity despite
surgery, hypoplasia of the optic nerve,
albinism with macular aplasia, or
bilateral optic atrophy); or
2. Abnormal neuroimaging
documenting damage to the cerebral
cortex which would be expected to
prevent the development of a visual
acuity better than 20/200 in the better
eye (such as neuroimaging showing
bilateral encephalomyelitis or bilateral
encephalomalacia); or
3. Abnormal electroretinogram
documenting the presence of Leber’s
congenital amaurosis or achromatopsia
in the better eye; or
4. An absent response to VER testing
in the better eye.
102.03 Contraction of the visual
field in the better eye, with:
A. The widest diameter subtending an
angle around the point of fixation no
greater than 20 degrees.
OR
B. An MD of 22 decibels or greater,
determined by automated static
threshold perimetry that measures the
central 30 degrees of the visual field (see
102.00A6d.).
OR
C. A visual field efficiency of 20
percent or less, determined by kinetic
perimetry (see 102.00A7c).
102.04 Loss of visual efficiency, or
visual impairment, in the better eye:
A. A visual efficiency percentage of
20 or less after best correction (see
102.00A7d.).
OR
B. A visual impairment value of 1.00
or greater after best correction (see
102.00A8d).
*
*
*
*
*
Certifications and Exemptions Under
the International Regulations for
Preventing Collisions at Sea, 1972
Department of the Navy, DoD.
Final rule.
AGENCY:
ACTION:
SUMMARY: The Department of the Navy
(DoN) is amending its certifications and
PO 00000
Frm 00052
Fmt 4700
Sfmt 4700
exemptions under the International
Regulations for Preventing Collisions at
Sea, 1972 (72 COLREGS), to reflect that
the Deputy Assistant Judge Advocate
General (DAJAG)(Admiralty and
Maritime Law) has determined that USS
MINNESOTA (SSN 783) is a vessel of
the Navy which, due to its special
construction and purpose, cannot fully
comply with certain provisions of the 72
COLREGS without interfering with its
special function as a naval ship. The
intended effect of this rule is to warn
mariners in waters where 72 COLREGS
apply.
DATES: This rule is effective March 28,
2013 and is applicable beginning March
11, 2013.
FOR FURTHER INFORMATION CONTACT:
Lieutenant Jocelyn Loftus-Williams,
(Admiralty and Maritime Law), Office of
the Judge Advocate General, Department
of the Navy, 1322 Patterson Ave. SE.,
Suite 3000, Washington Navy Yard, DC
20374–5066, telephone 202–685–5040.
SUPPLEMENTARY INFORMATION: Pursuant
to the authority granted in 33 U.S.C.
1605, the DoN amends 32 CFR Part 706.
This amendment provides notice that
the DAJAG (Admiralty and Maritime
Law), under authority delegated by the
Secretary of the Navy, has certified that
USS MINNESOTA (SSN 783) is a vessel
of the Navy which, due to its special
construction and purpose, cannot fully
comply with the following specific
provisions of 72 COLREGS without
interfering with its special function as a
naval ship: Annex I, paragraph 2(a)(i),
pertaining to the vertical placement of
the masthead light; Annex I, Section 2(f)
(i), pertaining to Virginia class
submarine masthead light location
below the submarine identification
lights; Annex I, paragraph 2(k),
pertaining to the vertical separation of
the anchor lights and vertical placement
of the forward anchor light above the
hull; Rule 30 (a) and Rule 21 (e),
pertaining to arc of visibility of the
forward and after anchor lights; Annex
I, paragraph 3(b), pertaining to the
location of the sidelights; and Rule
21(c), pertaining to the location and arc
of visibility of the sternlight. The
DAJAG (Admiralty and Maritime Law)
has also certified that the lights
involved are located in closest possible
compliance with the applicable 72
COLREGS requirements.
Moreover, it has been determined, in
accordance with 32 CFR Parts 296 and
701, that publication of this amendment
for public comment prior to adoption is
impracticable, unnecessary, and
contrary to public interest since it is
based on technical findings that the
placement of lights on this vessel in a
E:\FR\FM\28MRR1.SGM
28MRR1
Agencies
[Federal Register Volume 78, Number 60 (Thursday, March 28, 2013)]
[Rules and Regulations]
[Pages 18837-18846]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06975]
=======================================================================
-----------------------------------------------------------------------
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA-2010-0078]
RIN 0960-AH28
Revised Medical Criteria for Evaluating Visual Disorders
AGENCY: Social Security Administration.
ACTION: Final rules.
-----------------------------------------------------------------------
SUMMARY: We are revising and reorganizing the criteria in the Listing
of Impairments (listings) that we use to evaluate cases involving
visual disorders in adults and children under titles II and XVI of the
Social Security Act (Act). The revisions reflect our program experience
and guidance we have issued in response to adjudicator questions we
have received since we last revised these criteria in 2006. These
revisions will provide clarification about how we evaluate visual
disorders and ensure more timely adjudication of claims in which we
evaluate visual disorders that result in a loss of visual acuity or
field.
DATES: These rules are effective April 29, 2013.
FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of Medical
Listings Improvement, Social Security Administration, 6401 Security
Boulevard, Baltimore, Maryland 21235-6401, (410) 965-1020. For
information on eligibility or filing for benefits, call our national
toll-free number, 1-800-772-1213 or TTY 1-800-325-0778, or visit our
Internet site, Social Security Online, at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Background
We are making final the rules for evaluating visual disorders we
proposed in a notice of proposed rulemaking (NPRM) published in the
Federal Register on February 13, 2012 (77 FR 7549). The preamble to the
NPRM provides a full explanation of the background of these revisions.
You can view the preamble by visiting www.regulations.gov and searching
for document ``SSA-2010-0078-0001.'' We are making a number of changes
because of public comments to the NPRM. We explain those changes in our
summary of the public comments and our responses later in this
preamble. We are also making a number of minor editorial changes
throughout these final rules.
Why are we revising the listings for evaluating visual disorders?
We are revising the listings for evaluating visual disorders to
update the medical criteria, clarify how we evaluate visual disorders,
and address adjudicator questions.
When will we begin to use these final rules?
We will begin to use these final rules on their effective date. We
will continue to use the current rules until the date these final rules
become effective. We will apply the final rules to new applications
filed on or after the effective date of these final rules and to claims
that are pending on or after the effective date.\1\ These final rules
will remain in effect for 5 years after the date they become effective,
unless we extend them, or revise and issue them again.
---------------------------------------------------------------------------
\1\ This means that we will use these final rules on and after
their effective date in any case in which we make a determination or
decision. We expect that Federal courts will review our final
decisions using the rules that were in effect at the time we issued
the decisions. If a court reverses the Commissioner's final decision
and remands a case for further administrative proceedings after the
effective date of these final rules, we will apply these final rules
to the entire period at issue in the decision we make after the
court's remand.
---------------------------------------------------------------------------
Public Comments
In the NPRM, we provided the public with a 60-day comment period,
which ended on April 13, 2012. We received 12 public comment letters.
The comments came from members of the public, national medical
organizations, disability examiners, and a national association
representing disability examiners in the State agencies that make
disability determinations for us. We have summarized the comments below
because some of them were long. We summarized only those comments with
concerns or suggestions and responded to the significant issues that
were relevant to this rulemaking. Some commenters supported the
proposed changes and noted the provisions with which they agreed. While
we appreciate those comments, we have not summarized or responded to
them
[[Page 18838]]
below because they do not require a response.
Evidence
Comment: One commenter suggested that we replace the reference to
``physician or optometrist'' with ``optometrist or ophthalmologist'' in
2.00A4 and 102.00A4 where we explain what evidence we need to evaluate
visual disorders, including those that result in statutory blindness
under title II.
Response: We did not adopt this comment because we removed the
reference to ``physician or optometrist'' from those sections. When we
were considering this comment, we determined we did not need to include
the reference because our rules that explain the sources who can
provide evidence to establish an impairment are in 20 CFR 404.1513 and
416.913, and, therefore, we do not need to restate those sources in the
introductory text.
Vision Testing
Comment: One commenter suggested that we maintain the specific
references to the Humphrey Field Analyzer (HFA) and Octopus perimeters
that were provided in the introductory text. The commenter believed
that the specific references were essential for making accurate
determinations and decisions.
Response: We did not adopt this comment because we believe that
providing the requirements for acceptable perimeters and perimetry is
sufficient for accurate decisionmaking. We provide the requirements for
acceptable perimeters in 2.00A9 and 102.00A9. We also provide the
requirements for acceptable perimetry in 2.00A6 and 102.00A6 and
include examples of acceptable automated static threshold tests (HFA
30-2, HFA 24-2, and Octopus 32) that can be used to evaluate visual
field loss.
Comment: One commenter suggested that we develop a formula for
determining the intensity of the stimulus based on the maximum stimulus
luminance of the instrument rather than include two examples in
2.00A6b(iii) and 102.00A6b(iii).
Response: We did not adopt the commenter's suggestion that we
develop a formula to determine the intensity of the stimulus, but we
did make a change in the final rules to address the commenter's
concern. We added a third example (2.00Ab(iii)C and 102.00Ab(iii)C), so
the listings now include the most common maximum stimulus luminances on
automated static threshold perimeters.
Comment: One commenter said that the mean deviation in 2.03B and
102.03B varies by age and suggested that we reconsider using mean
deviation as a listing criterion.
Response: We did not adopt this comment. As we said when we
published the final rule in 2006 (71 FR 67013), the National Research
Council recommended that a mean deviation of 22 or worse on an
automated static threshold test measuring the central 30 degrees of the
visual field would serve as a reasonable criterion for disability
determination. We continue to agree with that recommendation.\2\
---------------------------------------------------------------------------
\2\ National Research Council, Committee on Disability
Determination for Individuals with Visual Impairments. (2002).
Visual Impairments: Determining Eligibility for Social Security
Benefits. Washington, DC: National Academy Press. Retrieved from
https://www.nap.edu/catalog/10320.html?se_side.
---------------------------------------------------------------------------
Comment: One commenter requested that we provide guidance on how to
interpret and assess medical findings included in the case file that
are outside of the specified testing requirements.
Response: We did not adopt this comment. We cannot provide guidance
on how to use all vision tests. We believe that it is sufficient to
provide specific guidance on the testing that is required to meet the
listings. All other testing found in the medical evidence can be
evaluated with the totality of the evidence when making a determination
or decision at other steps in the sequential evaluation.
Commenter: One commenter said that our use of the term
``cycloplegic refraction'' in proposed listing sections 2.00A5d and
102.00A5d is incorrect and suggested that we revise the definition for
clarity and accuracy. The commenter also noted that cycloplegic
refraction is a part of a comprehensive eye examination and may be used
to provide a more precise measurement of refractive error.
Response: We partially adopted this comment. We revised the
definition of ``cycloplegic refraction'' in 2.00A5d and 102.00A5d, but
we did not adopt the commenter's suggestion to note that cycloplegic
refraction is a part of a comprehensive eye examination. Rather, we
deleted the statement in the proposed rules that said cycloplegic
refraction testing is not part of a routine examination.
Evaluating Vision Loss in Young Children
Comment: One commenter suggested that we modify the behavioral
criteria in 102.02B for evaluating visual acuity in pre-verbal children
by stating that the inability to fixate and pursue a one-inch toy at
one foot with the better eye qualifies as legal blindness in children
over one year of age. Another commenter suggested that we provide
additional guidance in 102.00A for evaluating vision loss in young
children.
Response: We did not adopt these comments. We believe that the
guidance we provide in 102.00A5a(iv) sufficiently addresses the fact
that very young children test differently from older children. We
believe the requirements of 102.02B adequately address the possible
issues that may arise when testing very young children. There is no
need to modify the behavioral criteria. We did, however, clarify in
final 102.00A5a(iv) that the inability to participate in testing using
Snellen methodology or other comparable testing must be ``due to your
young age.''
Scotomas
Comment: One commenter suggested that we expand our guidance on
scotomas in 2.00A6h by including information about how scotomas affect
visual fields. The commenter also suggested that we provide guidance on
the test instruments that would be best for measuring and evaluating
the limitations caused by the scotoma.
Response: We did not adopt this comment. We clarify the definition
of scotoma by including ``field defect'' in addition to a ``non-seeing
area.'' We believe that the guidance we provide in 2.00A6h (and
102.00A6h) for how we consider scotomas when evaluating vision loss, in
addition to the guidance in 2.00A6a, 2.00A6b, and 2.00A6e (and
102.00A6a, 102.00A6b, and 102.00A6e) on acceptable perimeters, explains
sufficiently how scotomas affect visual fields, how we consider
scotomas, and which instruments are best for measuring visual field
loss.
Social Security Act
Comment: Several commenters recommended that we amend the language
used in the Act regarding blindness.
Response: We did not adopt these comments. We use the language in
the Act in our regulations because we do not have the authority to
revise the language Congress used in the Act without Congressional
legislation.
Visual Efficiency
Comment: One commenter noted that the sum of the eight principal
meridians we identify in the right eye in Figure 1 in 2.00A7 is
incorrect. The commenter noted that the correct sum of the principal
meridians should be 530 instead of 500.
[[Page 18839]]
Response: We partially adopted this comment. We revised Figure 1 in
2.00A7 and 102.00A7 to show the points on the principal meridians
clearly. However, because we are using the figure to explain a visual
efficiency percentage of 100 percent, the sum of the meridians remains
500.
Comment: One commenter believed that we should clarify our guidance
on visual efficiency values and percentages to make it easier to
differentiate between the two. The commenter said that the term
``efficiency value'' is inappropriate because it indicates impairment
rather than severity, and the commenter suggested that we use the term
``impairment value.'' The commenter also believed that Table 1 in
2.00A7 is confusing because it contains both values and percentages.
Response: We adopted these comments. We have revised 2.00A7 and
102.00A7, and added 2.00A8 and 102.00A8 to include language that
clarifies the differences between visual acuity efficiency values and
visual acuity efficiency percentages. We also revised the listing
criteria for 2.04 and 102.04 to reflect the clarification.
Lenses
Comment: One commenter suggested that we remove the phrase
``because they significantly reduce the visual field'' from our
guidance on telescopic lenses in 2.00A5c because reduced field is only
one of many reasons why telescopic lenses should not be used to test
visual acuity.
Response: We adopted this comment. We agree that there are several
reasons that the telescopic lens should not be used to test visual
acuity. It is unnecessary to provide an explanation for why each reason
is unacceptable for our purposes. We believe that it is sufficient to
simply state that visual acuity measurements obtained with telescopic
lenses are unacceptable.
Comment: One commenter stated that our use of ``perimetric lenses''
in proposed 2.00A6g and 102.00A6g is outdated because these types of
lenses are rarely used in modern medical practice. The commenter
believed that it would be more logical to measure visual fields using
the person's usual mode of corrective lenses.
Response: We partially adopted this comment. One of the goals of
updating our regulations is to address advances in medical technology
and terminology. We have removed the term ``perimetric lenses'' from
2.00A6g. We did not adopt the comment about using the person's usual
mode of corrective lenses for testing. We continue to provide our
guidance that eyeglasses should not be worn during visual field
testing. Visual field testing accommodates the need for eyeglasses or
other corrective lenses, allowing for accurate measurement of visual
fields.
What is our authority to make rules and set procedures for determining
whether a person is disabled under the statutory definition?
The Act authorizes us to make rules and regulations and to
establish necessary and appropriate procedures to implement them.
Sections 205(a), 702(a)(5), and 1631(d)(1).
Regulatory Procedures
Executive Order 12866, as Supplemented by Executive Order 13563
We have consulted with the Office of Management and Budget (OMB)
and determined that these final rules meet the criteria for a
significant regulatory action under Executive Order 12866, as
supplemented by Executive Order 13563. Therefore, OMB reviewed them.
Regulatory Flexibility Act
We certify that these final rules will not have a significant
economic impact on a substantial number of small entities because they
affect individuals only. Therefore, the Regulatory Flexibility Act, as
amended, does not require us to prepare a regulatory flexibility
analysis.
Paperwork Reduction Act
These rules do not create any new or affect any existing
collections and, therefore, do not require Office of Management and
Budget approval under the Paperwork Reduction Act.
(Catalog of Federal Domestic Assistance Program Nos. 96.001, Social
Security--Disability Insurance; 96.002, Social Security--Retirement
Insurance; 96.004, Social Security--Survivors Insurance; and 96.006,
Supplemental Security Income).
List of Subjects in 20 CFR Part 404
Administrative practice and procedure; Blind, Disability benefits;
Old-Age, Survivors, and Disability Insurance; Reporting and
recordkeeping requirements; Social Security.
Carolyn W. Colvin,
Acting Commissioner of Social Security.
For the reasons set out in the preamble, we are amending 20 CFR
chapter III, part 404, subpart P as set forth below:
PART 404--FEDERAL OLD-AGE, SURVIVORS AND DISABILITY INSURANCE
(1950-)
Subpart P--[Amended]
0
1. The authority citation for subpart P of part 404 continues to read
as follows:
Authority: Secs. 202, 205(a)-(b) and (d)-(h), 216(i), 221(a),
(i), and (j), 222(c), 223, 225, and 702(a)(5) of the Social Security
Act (42 U.S.C. 402, 405(a)-(b) and (d)-(h), 416(i), 421(a), (i), and
(j), 422(c), 423, 425, and 902(a)(5)); sec. 211(b), Pub. L. 104-193,
110 Stat. 2105, 2189; sec. 202, Pub. L. 108-203, 118 Stat. 509 (42
U.S.C. 902 note).
0
2. Amend appendix 1 to subpart P of part 404 by:
0
a. Revising item 3 of the introductory text before part A.
0
b. Revising section 2.00A in part A.
0
c. Revising sections 2.01 through 2.04 in part A.
0
d. Revising section 102.00A in part B.
0
e. Revising sections 102.101 through 102.104 in part B.
The revisions read as follows:
Appendix 1 to Subpart P of Part 404--Listing of Impairments
* * * * *
0
3. Special Senses and Speech (2.00 and 102.00): April 29, 2018.
* * * * *
Part A
* * * * *
2.00 SPECIAL SENSES AND SPEECH
A. How do we evaluate visual disorders?
1. What are visual disorders? Visual disorders are abnormalities of
the eye, the optic nerve, the optic tracts, or the brain that may cause
a loss of visual acuity or visual fields. A loss of visual acuity
limits your ability to distinguish detail, read, or do fine work. A
loss of visual fields limits your ability to perceive visual stimuli in
the peripheral extent of vision.
2. How do we define statutory blindness? Statutory blindness is
blindness as defined in sections 216(i)(1) and 1614(a)(2) of the Social
Security Act (Act).
a. The Act defines blindness as central visual acuity of 20/200 or
less in the better eye with the use of a correcting lens. We use your
best-corrected central visual acuity for distance in the better eye
when we determine if this definition is met. (For visual acuity testing
requirements, see 2.00A5.)
b. The Act also provides that an eye that has a visual field
limitation such that the widest diameter of the visual field subtends
an angle no greater than 20 degrees is considered as having a
[[Page 18840]]
central visual acuity of 20/200 or less. (For visual field testing
requirements, see 2.00A6.)
c. You have statutory blindness only if your visual disorder meets
the criteria of 2.02 or 2.03A. You do not have statutory blindness if
your visual disorder medically equals the criteria of 2.02 or 2.03A or
meets or medically equals the criteria of 2.03B, 2.03C, 2.04A, or 2.04B
because your disability is based on criteria other than those in the
statutory definition of blindness.
3. What evidence do we need to establish statutory blindness under
title XVI? To establish that you have statutory blindness under title
XVI, we need evidence showing only that your central visual acuity in
your better eye or your visual field in your better eye meets the
criteria in 2.00A2, provided that those measurements are consistent
with the other evidence in your case record. We do not need
documentation of the cause of your blindness. Also, there is no
duration requirement for statutory blindness under title XVI (see
Sec. Sec. 416.981 and 416.983 of this chapter).
4. What evidence do we need to evaluate visual disorders, including
those that result in statutory blindness under title II? To evaluate
your visual disorder, we usually need a report of an eye examination
that includes measurements of your best-corrected central visual acuity
(see 2.00A5) or the extent of your visual fields (see 2.00A6), as
appropriate. If you have visual acuity or visual field loss, we need
documentation of the cause of the loss. A standard eye examination will
usually indicate the cause of any visual acuity loss. A standard eye
examination can also indicate the cause of some types of visual field
deficits. Some disorders, such as cortical visual disorders, may result
in abnormalities that do not appear on a standard eye examination. If
the standard eye examination does not indicate the cause of your vision
loss, we will request the information used to establish the presence of
your visual disorder. If your visual disorder does not satisfy the
criteria in 2.02, 2.03, or 2.04, we will request a description of how
your visual disorder affects your ability to function.
5. How do we measure your best-corrected central visual acuity?
a. Visual acuity testing. When we need to measure your best-
corrected central visual acuity (your optimal visual acuity attainable
with the use of a corrective lens), we use visual acuity testing for
distance that was carried out using Snellen methodology or any other
testing methodology that is comparable to Snellen methodology.
(i) Your best-corrected central visual acuity for distance is
usually measured by determining what you can see from 20 feet. If your
visual acuity is measured for a distance other than 20 feet, we will
convert it to a 20-foot measurement. For example, if your visual acuity
is measured at 10 feet and is reported as 10/40, we will convert this
measurement to 20/80.
(ii) A visual acuity recorded as CF (counts fingers), HM (hand
motion only), LP or LPO (light perception or light perception only), or
NLP (no light perception) indicates that no optical correction will
improve your visual acuity. If your central visual acuity in an eye is
recorded as CF, HM, LP or LPO, or NLP, we will determine that your
best-corrected central visual acuity is 20/200 or less in that eye.
(iii) We will not use the results of pinhole testing or automated
refraction acuity to determine your best-corrected central visual
acuity. These tests provide an estimate of potential visual acuity but
not an actual measurement of your best-corrected central visual acuity.
b. Other test charts. Most test charts that use Snellen methodology
do not have lines that measure visual acuity between 20/100 and 20/200.
Some test charts, such as the Bailey-Lovie or the Early Treatment
Diabetic Retinopathy Study (ETDRS), used mostly in research settings,
have such lines. If your visual acuity is measured with one of these
charts, and you cannot read any of the letters on the 20/100 line, we
will determine that you have statutory blindness based on a visual
acuity of 20/200 or less. For example, if your best-corrected central
visual acuity for distance in the better eye is 20/160 using an ETDRS
chart, we will find that you have statutory blindness. Regardless of
the type of test chart used, you do not have statutory blindness if you
can read at least one letter on the 20/100 line. For example, if your
best-corrected central visual acuity for distance in the better eye is
20/125+1 using an ETDRS chart, we will find that you do not have
statutory blindness because you are able to read one letter on the 20/
100 line.
c. Testing using a specialized lens. In some instances, you may
have visual acuity testing performed using specialized lens, such as a
contact lens. We will use the visual acuity measurements obtained with
a specialized lens only if you have demonstrated the ability to use the
specialized lens on a sustained basis. We will not use visual acuity
measurements obtained with telescopic lenses.
d. Cycloplegic refraction is an examination of the eye performed
after administering cycloplegic eye drops capable of relaxing the
ability of the pupil to become smaller and temporarily paralyzing the
focusing muscles. If your case record contains the results of
cycloplegic refraction, we may use the results to determine your best-
corrected central visual acuity. We will not purchase cycloplegic
refraction.
e. Visual evoked response (VER) testing measures your response to
visual events and can often detect dysfunction that is undetectable
through other types of examinations. If you have an absent response to
VER testing in your better eye, we will determine that your best-
corrected central visual acuity is 20/200 or less in that eye and that
your visual acuity loss satisfies the criterion in 2.02 when these test
results are consistent with the other evidence in your case record. If
you have a positive response to VER testing in an eye, we will not use
that result to determine your best-corrected central visual acuity in
that eye.
6. How do we measure your visual fields?
a. General. We generally need visual field testing when you have a
visual disorder that could result in visual field loss, such as
glaucoma, retinitis pigmentosa, or optic neuropathy, or when you
display behaviors that suggest a visual field loss. When we need to
measure the extent of your visual field loss, we use visual field
testing (also referred to as perimetry) carried out using automated
static threshold perimetry performed on an acceptable perimeter. (For
perimeter requirements, see 2.00A9.)
b. Automated static threshold perimetry requirements.
(i) The test must use a white size III Goldmann stimulus and a 31.5
apostilb (asb) white background (or a 10 candela per square meter (cd/
m\2\) white background). The stimuli test locations must be no more
than 6 degrees apart horizontally or vertically. Measurements must be
reported on standard charts and include a description of the size and
intensity of the test stimulus.
(ii) We measure the extent of your visual field loss by determining
the portion of the visual field in which you can see a white III4e
stimulus. The ``III'' refers to the standard Goldmann test stimulus
size III (4 mm\2\), and the ``4e'' refers to the standard Goldmann
intensity filter (0 decibel (dB) attenuation, which allows presentation
of the maximum luminance) used to determine the intensity of the
stimulus.
(iii) In automated static threshold perimetry, the intensity of the
stimulus
[[Page 18841]]
varies. The intensity of the stimulus is expressed in decibels (dB). A
perimeter's maximum stimulus luminance is usually assigned the value 0
dB. We need to determine the dB level that corresponds to a 4e
intensity for the particular perimeter being used. We will then use the
dB printout to determine which points you see at a 4e intensity level
(a ``seeing point''). For example:
A. When the maximum stimulus luminance (0 dB stimulus) on an
acceptable perimeter is 10,000 asb, a 10 dB stimulus is equivalent to a
4e stimulus. Any point you see at 10 dB or greater is a seeing point.
B. When the maximum stimulus luminance (0 dB stimulus) on an
acceptable perimeter is 4,000 asb, a 6 dB stimulus is equivalent to a
4e stimulus. Any point you see at 6 dB or greater is a seeing point.
C. When the maximum stimulus luminance (0 dB stimulus) on an
acceptable perimeter is 1,000 asb, a 0 dB stimulus is equivalent to a
4e stimulus. Any point you see at 0 dB or greater is a seeing point.
c. Evaluation under 2.03A. To determine statutory blindness based
on visual field loss in your better eye (2.03A), we need the results of
a visual field test that measures the central 24 to 30 degrees of your
visual field; that is, the area measuring 24 to 30 degrees from the
point of fixation. Acceptable tests include the Humphrey Field Analyzer
(HFA) 30-2, HFA 24-2, and Octopus 32.
d. Evaluation under 2.03B. To determine whether your visual field
loss meets listing 2.03B, we use the mean deviation or defect (MD) from
acceptable automated static threshold perimetry that measures the
central 30 degrees of the visual field. MD is the average sensitivity
deviation from normal values for all measured visual field locations.
When using results from HFA tests, which report the MD as a negative
number, we use the absolute value of the MD to determine whether your
visual field loss meets listing 2.03B. We cannot use tests that do not
measure the central 30 degrees of the visual field, such as the HFA 24-
2, to determine if your impairment meets or medically equals 2.03B.
e. Other types of perimetry. If the evidence in your case contains
visual field measurements obtained using manual or automated kinetic
perimetry, such as Goldmann perimetry or the HFA ``SSA Test Kinetic,''
we can generally use these results if the kinetic test was performed
using a white III4e stimulus projected on a white 31.5 asb (10 cd/m\2\)
background. Automated kinetic perimetry, such as the HFA ``SSA Test
Kinetic,'' does not detect limitations in the central visual field
because testing along a meridian stops when you see the stimulus. If
your visual disorder has progressed to the point at which it is likely
to result in a significant limitation in the central visual field, such
as a scotoma (see 2.00A6h), we will not use automated kinetic perimetry
to determine the extent of your visual field loss. Instead, we will
determine the extent of your visual field loss using automated static
threshold perimetry or manual kinetic perimetry.
f. Screening tests. We will not use the results of visual field
screening tests, such as confrontation tests, tangent screen tests, or
automated static screening tests, to determine that your impairment
meets or medically equals a listing or to evaluate your residual
functional capacity. We can consider normal results from visual field
screening tests to determine whether your visual disorder is severe
when these test results are consistent with the other evidence in your
case record. (See Sec. Sec. 404.1520(c), 404.1521, 416.920(c), and
416.921 of this chapter.) We will not consider normal test results to
be consistent with the other evidence if the clinical findings indicate
that your visual disorder has progressed to the point that it is likely
to cause visual field loss, or you have a history of an operative
procedure for retinal detachment.
g. Use of corrective lenses. You must not wear eyeglasses during
visual field testing because they limit your field of vision. You may
wear contact lenses to correct your visual acuity during the visual
field test to obtain the most accurate visual field measurements. For
this single purpose, you do not need to demonstrate that you have the
ability to use the contact lenses on a sustained basis.
h. Scotoma. A scotoma is a field defect or non-seeing area (also
referred to as a ``blind spot'') in the visual field surrounded by a
normal field or seeing area. When we measure your visual field, we
subtract the length of any scotoma, other than the normal blind spot,
from the overall length of any diameter on which it falls.
7. How do we determine your visual acuity efficiency, visual field
efficiency, and visual efficiency?
a. General. Visual efficiency, a calculated value of your remaining
visual function, is the combination of your visual acuity efficiency
and your visual field efficiency expressed as a percentage.
b. Visual acuity efficiency. Visual acuity efficiency is a
percentage that corresponds to the best-corrected central visual acuity
for distance in your better eye. See Table 1.
Table 1--Visual Acuity Efficiency
------------------------------------------------------------------------
Snellen best-corrected central visual acuity for
distance Visual acuity
------------------------------------------------- efficiency (%) (2.04A)
English Metric
------------------------------------------------------------------------
20/16 6/5 100
20/20 6/6 100
20/25 6/7.5 95
20/30 6/9 90
20/40 6/12 85
20/50 6/15 75
20/60 6/18 70
20/70 6/21 65
20/80 6/24 60
20/100 6/30 50
------------------------------------------------------------------------
c. Visual field efficiency. Visual field efficiency is a percentage
that corresponds to the visual field in your better eye. Under 2.03C,
we require kinetic perimetry to determine your visual field efficiency
percentage. We calculate the visual field efficiency percentage by
adding the number of degrees you see along the eight principal
meridians found on a visual field chart (0, 45, 90, 135, 180, 225, 270,
and 315) in your better eye and dividing by 5. For example, in Figure
1:
A. The diagram of the left eye illustrates a visual field, as
measured with a III4e stimulus, contracted to 30 degrees in two
meridians (180 and 225) and to 20 degrees in the remaining six
meridians. The visual efficiency percentage of this field is: ((2 x 30)
+ (6 x 20)) / 5 = 36 percent.
B. The diagram of the right eye illustrates the extent of a normal
visual field as measured with a III4e stimulus. The sum of the eight
principal meridians of this field is 500 degrees. The visual efficiency
percentage of this field is 500 / 5 = 100 percent.
[[Page 18842]]
[GRAPHIC] [TIFF OMITTED] TR28MR13.002
d. Visual efficiency. Under 2.04A, we calculate the visual
efficiency percentage by multiplying your visual acuity efficiency
percentage (see 2.00A7b) by your visual field efficiency percentage
(see 2.00A7c) and dividing by 100. For example, if your visual acuity
efficiency percentage is 75 and your visual field efficiency percentage
is 36, your visual efficiency percentage is: (75 x 36) / 100 = 27
percent.
8. How do we determine your visual acuity impairment value, visual
field impairment value, and visual impairment value?
a. General. Visual impairment value, a calculated value of your
loss of visual function, is the combination of your visual acuity
impairment value and your visual field impairment value.
b. Visual acuity impairment value. Your visual acuity impairment
value corresponds to the best-corrected central visual acuity for
distance in your better eye. See Table 2.
Table 2--Visual Acuity Impairment Value
------------------------------------------------------------------------
------------------------------------------------------------------------
Snellen best-corrected central visual acuity for Visual acuity
distance impairment
value (2.04B)
------------------------------------------------------------------------
English Metric
------------------------------------------------------------------------
20/16 6/5 0.00
20/20 6/6 0.00
20/25 6/7.5 0.10
20/30 6/9 0.18
20/40 6/12 0.30
20/50 6/15 0.40
20/60 6/18 0.48
20/70 6/21 0.54
20/80 6/24 0.60
20/100 6/30 0.70
------------------------------------------------------------------------
c. Visual field impairment value. Your visual field impairment
value corresponds to the visual field in your better eye. Using the MD
from acceptable automated static threshold perimetry, we calculate the
visual field impairment value by dividing the absolute value of the MD
by 22. For example, if your MD on an HFA 30-2 is -16, your visual field
impairment value is: -16 / 22 = 0.73.
d. Visual impairment value. Under 2.04B, we calculate the visual
impairment value by adding your visual acuity impairment value (see
2.00A8b) and your visual field impairment value (see 2.00A8c). For
example, if your visual acuity impairment value is 0.48 and your visual
field impairment value is 0.73, your visual impairment value is: 0.48 +
0.73 = 1.21.
9. What are our requirements for an acceptable perimeter? We will
use results from automated static threshold perimetry performed on a
perimeter that:
a. Uses optical projection to generate the test stimuli.
b. Has an internal normative database for automatically comparing
your performance with that of the general population.
c. Has a statistical analysis package that is able to calculate
visual field indices, particularly MD.
d. Demonstrates the ability to correctly detect visual field loss
and correctly identify normal visual fields.
e. Demonstrates good test-retest reliability.
f. Has undergone clinical validation studies by three or more
independent laboratories with results published in peer-reviewed
ophthalmic journals.
* * * * *
2.01 Category of Impairments, Special Senses and Speech
2.02 Loss of central visual acuity. Remaining vision in the better
eye after best correction is 20/200 or less.
2.03 Contraction of the visual field in the better eye, with:
A. The widest diameter subtending an angle around the point of
fixation no greater than 20 degrees.
OR
B. An MD of 22 decibels or greater, determined by automated static
threshold perimetry that measures the central 30 degrees of the visual
field (see 2.00A6d).
OR
[[Page 18843]]
C. A visual field efficiency of 20 percent or less, determined by
kinetic perimetry (see 2.00A7c).
2.04 Loss of visual efficiency, or visual impairment, in the better
eye:
A. A visual efficiency percentage of 20 or less after best
correction (see 2.00A7d).
OR
B. A visual impairment value of 1.00 or greater after best
correction (see 2.00A8d).
* * * * *
Part B
* * * * *
102.00 SPECIAL SENSES AND SPEECH
A. How do we evaluate visual disorders?
1. What are visual disorders? Visual disorders are abnormalities of
the eye, the optic nerve, the optic tracts, or the brain that may cause
a loss of visual acuity or visual fields. A loss of visual acuity
limits your ability to distinguish detail, read, do fine work, or
perform other age-appropriate activities. A loss of visual fields
limits your ability to perceive visual stimuli in the peripheral extent
of vision.
2. How do we define statutory blindness? Statutory blindness is
blindness as defined in sections 216(i)(1) and 1614(a)(2) of the Social
Security Act (Act).
a. The Act defines blindness as central visual acuity of 20/200 or
less in the better eye with the use of a correcting lens. We use your
best-corrected central visual acuity for distance in the better eye
when we determine if this definition is met. (For visual acuity testing
requirements, see 102.00A5.)
b. The Act also provides that an eye that has a visual field
limitation such that the widest diameter of the visual field subtends
an angle no greater than 20 degrees is considered as having a central
visual acuity of 20/200 or less. (For visual field testing
requirements, see 102.00A6.)
c. You have statutory blindness only if your visual disorder meets
the criteria of 102.02A, 102.02B, or 102.03A. You do not have statutory
blindness if your visual disorder medically equals the criteria of
102.02A, 102.02B, or 102.03A or meets or medically equals the criteria
of 102.03B, 102.03C, 102.04A, or 102.04B because your disability is
based on criteria other than those in the statutory definition of
blindness.
3. What evidence do we need to establish statutory blindness under
title XVI? To establish that you have statutory blindness under title
XVI, we need evidence showing only that your central visual acuity in
your better eye or your visual field in your better eye meets the
criteria in 102.00A2, provided that those measurements are consistent
with the other evidence in your case record. We do not need
documentation of the cause of your blindness. Also, there is no
duration requirement for statutory blindness under title XVI (see
Sec. Sec. 416.981 and 416.983 of this chapter).
4. What evidence do we need to evaluate visual disorders, including
those that result in statutory blindness under title II? To evaluate
your visual disorder, we usually need a report of an eye examination
that includes measurements of your best-corrected central visual acuity
(see 102.00A5) or the extent of your visual fields (see 102.00A6), as
appropriate. If you have visual acuity or visual field loss, we need
documentation of the cause of the loss. A standard eye examination will
usually indicate the cause of any visual acuity loss. A standard eye
examination can also indicate the cause of some types of visual field
deficits. Some disorders, such as cortical visual disorders, may result
in abnormalities that do not appear on a standard eye examination. If
the standard eye examination does not indicate the cause of your vision
loss, we will request the information used to establish the presence of
your visual disorder. If your visual disorder does not satisfy the
criteria in 102.02, 102.03, or 102.04, we will request a description of
how your visual disorder affects your ability to function.
5. How do we measure your best-corrected central visual acuity?
a. Visual acuity testing. When we need to measure your best-
corrected central visual acuity, which is your optimal visual acuity
attainable with the use of a corrective lens, we use visual acuity
testing for distance that was carried out using Snellen methodology or
any other testing methodology that is comparable to Snellen
methodology.
(i) Your best-corrected central visual acuity for distance is
usually measured by determining what you can see from 20 feet. If your
visual acuity is measured for a distance other than 20 feet, we will
convert it to a 20-foot measurement. For example, if your visual acuity
is measured at 10 feet and is reported as 10/40, we will convert this
measurement to 20/80.
(ii) A visual acuity recorded as CF (counts fingers), HM (hand
motion only), LP or LPO (light perception or light perception only), or
NLP (no light perception) indicates that no optical correction will
improve your visual acuity. If your central visual acuity in an eye is
recorded as CF, HM, LP or LPO, or NLP, we will determine that your
best-corrected central visual acuity is 20/200 or less in that eye.
(iii) We will not use the results of pinhole testing or automated
refraction acuity to determine your best-corrected central visual
acuity. These tests provide an estimate of potential visual acuity but
not an actual measurement of your best-corrected central visual acuity.
(iv) Very young children, such as infants and toddlers, cannot
participate in testing using Snellen methodology or other comparable
testing. If you are unable to participate in testing using Snellen
methodology or other comparable testing due to your young age, we will
consider clinical findings of your fixation and visual-following
behavior. If both these behaviors are absent, we will consider the
anatomical findings or the results of neuroimaging, electroretinogram,
or visual evoked response (VER) testing when this testing has been
performed.
b. Other test charts.
(i) Children between the ages of 3 and 5 often cannot identify the
letters on a Snellen or other letter test chart. Specialists with
expertise in assessment of childhood vision use alternate methods for
measuring visual acuity in young children. We consider alternate
methods, for example, the Landolt C test or the tumbling-E test, which
are used to evaluate young children who are unable to participate in
testing using Snellen methodology, to be comparable to testing using
Snellen methodology.
(ii) Most test charts that use Snellen methodology do not have
lines that measure visual acuity between 20/100 and 20/200. Some test
charts, such as the Bailey-Lovie or the Early Treatment Diabetic
Retinopathy Study (ETDRS), used mostly in research settings, have such
lines. If your visual acuity is measured with one of these charts, and
you cannot read any of the letters on the 20/100 line, we will
determine that you have statutory blindness based on a visual acuity of
20/200 or less. For example, if your best-corrected central visual
acuity for distance in the better eye is 20/160 using an ETDRS chart,
we will find that you have statutory blindness. Regardless of the type
of test chart used, you do not have statutory blindness if you can read
at least one letter on the 20/100 line. For example, if your best-
corrected central visual acuity for distance in the better eye is 20/
125+1 using an ETDRS chart, we will find that you do not have statutory
blindness because you are able to read one letter on the 20/100 line.
[[Page 18844]]
c. Testing using a specialized lens. In some instances, you may
have visual acuity testing performed using a specialized lens, such as
a contact lens. We will use the visual acuity measurements obtained
with a specialized lens only if you have demonstrated the ability to
use the specialized lens on a sustained basis. We will not use visual
acuity measurements obtained with telescopic lenses.
d. Cycloplegic refraction is an examination of the eye performed
after administering cycloplegic eye drops capable of relaxing the
ability of the pupil to become smaller and temporarily paralyzing the
focusing muscles. If your case record contains the results of
cycloplegic refraction, we may use the results to determine your best-
corrected central visual acuity. We will not purchase cycloplegic
refraction.
e. VER testing measures your response to visual events and can
often detect dysfunction that is undetectable through other types of
examinations. If you have an absent response to VER testing in your
better eye, we will determine that your best-corrected central visual
acuity is 20/200 or less in that eye and that your visual acuity loss
satisfies the criterion in 102.02A or 102.02B4, as appropriate, when
these test results are consistent with the other evidence in your case
record. If you have a positive response to VER testing in an eye, we
will not use that result to determine your best-corrected central
visual acuity in that eye.
6. How do we measure your visual fields?
a. General. We generally need visual field testing when you have a
visual disorder that could result in visual field loss, such as
glaucoma, retinitis pigmentosa, or optic neuropathy, or when you
display behaviors that suggest a visual field loss. When we need to
measure the extent of your visual field loss, we use visual field
testing (also referred to as perimetry) carried out using automated
static threshold perimetry performed on an acceptable perimeter. (For
perimeter requirements, see 102.00A9.)
b. Automated static threshold perimetry requirements.
(i) The test must use a white size III Goldmann stimulus and a 31.5
apostilb (asb) white background (or a 10 candela per square meter (cd/
m\2\) white background). The stimuli test locations must be no more
than 6 degrees apart horizontally or vertically. Measurements must be
reported on standard charts and include a description of the size and
intensity of the test stimulus.
(ii) We measure the extent of your visual field loss by determining
the portion of the visual field in which you can see a white III4e
stimulus. The ``III'' refers to the standard Goldmann test stimulus
size III (4 mm\2\), and the ``4e'' refers to the standard Goldmann
intensity filter (0 decibel (dB) attenuation, which allows presentation
of the maximum luminance) used to determine the intensity of the
stimulus.
(iii) In automated static threshold perimetry, the intensity of the
stimulus varies. The intensity of the stimulus is expressed in decibels
(dB). A perimeter's maximum stimulus luminance is usually assigned the
value 0 dB. We need to determine the dB level that corresponds to a 4e
intensity for the particular perimeter being used. We will then use the
dB printout to determine which points you see at a 4e intensity level
(a ``seeing point''). For example:
A. When the maximum stimulus luminance (0 dB stimulus) on an
acceptable perimeter is 10,000 asb, a 10 dB stimulus is equivalent to a
4e stimulus. Any point you see at 10 dB or greater is a seeing point.
B. When the maximum stimulus luminance (0 dB stimulus) on an
acceptable perimeter is 4,000 asb, a 6 dB stimulus is equivalent to a
4e stimulus. Any point you see at 6 dB or greater is a seeing point.
C. When the maximum stimulus luminance (0 dB stimulus) on an
acceptable perimeter is 1,000 asb, a 0 dB stimulus is equivalent to a
4e stimulus. Any point you see at 0 dB or greater is a seeing point.
c. Evaluation under 102.03A. To determine statutory blindness based
on visual field loss in your better eye (102.03A), we need the results
of a visual field test that measures the central 24 to 30 degrees of
your visual field; that is, the area measuring 24 to 30 degrees from
the point of fixation. Acceptable tests include the Humphrey Field
Analyzer (HFA) 30-2, HFA 24-2, and Octopus 32.
d. Evaluation under 102.03B. To determine whether your visual field
loss meets listing 102.03B, we use the mean deviation or defect (MD)
from acceptable automated static threshold perimetry that measures the
central 30 degrees of the visual field. MD is the average sensitivity
deviation from normal values for all measured visual field locations.
When using results from HFA tests, which report the MD as a negative
number, we use the absolute value of the MD to determine whether your
visual field loss meets listing 102.03B. We cannot use tests that do
not measure the central 30 degrees of the visual field, such as the HFA
24-2, to determine if your impairment meets or medically equals
102.03B.
e. Other types of perimetry. If your case record contains visual
field measurements obtained using manual or automated kinetic
perimetry, such as Goldmann perimetry or the HFA ``SSA Test Kinetic,''
we can generally use these results if the kinetic test was performed
using a white III4e stimulus projected on a white 31.5 asb (10 cd/m\2\)
background. Automated kinetic perimetry, such as the HFA ``SSA Test
Kinetic,'' does not detect limitations in the central visual field
because testing along a meridian stops when you see the stimulus. If
your visual disorder has progressed to the point at which it is likely
to result in a significant limitation in the central visual field, such
as a scotoma (see 102.00A6h), we will not use automated kinetic
perimetry to determine the extent of your visual field loss. Instead,
we will determine the extent of your visual field loss using automated
static threshold perimetry or manual kinetic perimetry.
f. Screening tests. We will not use the results of visual field
screening tests, such as confrontation tests, tangent screen tests, or
automated static screening tests, to determine that your impairment
meets or medically equals a listing, or functionally equals the
listings. We can consider normal results from visual field screening
tests to determine whether your visual disorder is severe when these
test results are consistent with the other evidence in your case
record. (See Sec. 416.924(c) of this chapter.) We will not consider
normal test results to be consistent with the other evidence if the
clinical findings indicate that your visual disorder has progressed to
the point that it is likely to cause visual field loss, or you have a
history of an operative procedure for retinal detachment.
g. Use of corrective lenses. You must not wear eyeglasses during
visual field testing because they limit your field of vision. You may
wear contact lenses to correct your visual acuity during the visual
field test to obtain the most accurate visual field measurements. For
this single purpose, you do not need to demonstrate that you have the
ability to use the contact lenses on a sustained basis.
h. Scotoma. A scotoma is a field defect or non-seeing area (also
referred to as a ``blind spot'') in the visual field surrounded by a
normal field or seeing area. When we measure your visual field, we
subtract the length of any scotoma, other than the normal blind spot,
from the overall length of any diameter on which it falls.
[[Page 18845]]
7. How do we determine your visual acuity efficiency, visual field
efficiency, and visual efficiency?
a. General. Visual efficiency, a calculated value of your remaining
visual function, is the combination of your visual acuity efficiency
and your visual field efficiency expressed as a percentage.
b. Visual acuity efficiency. Visual acuity efficiency is a
percentage that corresponds to the best-corrected central visual acuity
for distance in your better eye. See Table 1.
Table 1--Visual Acuity Efficiency
------------------------------------------------------------------------
Snellen best-corrected central visual acuity for
distance Visual acuity
------------------------------------------------- efficiency (%)
English Metric (102.04A)
------------------------------------------------------------------------
20/16 6/5 100
20/20 6/6 100
20/25 6/7.5 95
20/30 6/9 90
20/40 6/12 85
20/50 6/15 75
20/60 6/18 70
20/70 6/21 65
20/80 6/24 60
20/100 6/30 50
------------------------------------------------------------------------
c. Visual field efficiency. Visual field efficiency is a percentage
that corresponds to the visual field in your better eye. Under 102.03C,
we require kinetic perimetry to determine your visual field efficiency
percentage. We calculate the visual field efficiency percentage by
adding the number of degrees you see along the eight principal
meridians found on a visual field chart (0, 45, 90, 135, 180, 225, 270,
and 315) in your better eye and dividing by 5. For example, in Figure
1:
A. The diagram of the left eye illustrates a visual field, as
measured with a III4e stimulus, contracted to 30 degrees in two
meridians (180 and 225) and to 20 degrees in the remaining six
meridians. The visual efficiency percentage of this field is: ((2 x 30)
+ (6 x 20)) / 5 = 36 percent.
B. The diagram of the right eye illustrates the extent of a normal
visual field as measured with a III4e stimulus. The sum of the eight
principal meridians of this field is 500 degrees. The visual efficiency
percentage of this field is 500 / 5 = 100 percent.
[GRAPHIC] [TIFF OMITTED] TR28MR13.003
d. Visual efficiency. Under 102.04A, we calculate the visual
efficiency percentage by multiplying your visual acuity efficiency
percentage (see 102.00A7b) by your visual field efficiency percentage
(see 102.00A7c) and dividing by 100. For example, if your visual acuity
efficiency percentage is 75 and your visual field efficiency percentage
is 36, your visual efficiency percentage is: (75 x 36) / 100 = 27
percent.
8. How do we determine your visual acuity impairment value, visual
field impairment value, and visual impairment value?
a. General. Visual impairment value, a calculated value of your
loss of visual function, is the combination of your visual acuity
impairment value and your visual field impairment value.
b. Visual acuity impairment value. Your visual acuity impairment
value corresponds to the best-corrected central visual acuity for
distance in your better eye. See Table 2.
Table 2--Visual Acuity Impairment Value
------------------------------------------------------------------------
Snellen best-corrected central visual acuity for
distance Visual acuity
------------------------------------------------- impairment value
English Metric (102.04B)
------------------------------------------------------------------------
20/16 6/5 0.00
20/20 6/6 0.00
20/25 6/7.5 0.10
20/30 6/9 0.18
20/40 6/12 0.30
20/50 6/15 0.40
20/60 6/18 0.48
20/70 6/21 0.54
[[Page 18846]]
20/80 6/24 0.60
20/100 6/30 0.70
------------------------------------------------------------------------
c. Visual field impairment value. Your visual field impairment
value corresponds to the visual field in your better eye. Using the MD
from acceptable automated static threshold perimetry, we calculate the
visual field impairment value by dividing the absolute value of the MD
by 22. For example, if your MD on an HFA 30-2 is -16, your visual field
impairment value is: [bond]-16[bond] / 22 = 0.73.
d. Visual impairment value. Under 102.04B, we calculate the visual
impairment value by adding your visual acuity impairment value (see
102.00A8b) and your visual field impairment value (see 102.00A8c). For
example, if your visual acuity impairment value is 0.48 and your visual
field impairment value is 0.73, your visual impairment value is: 0.48 +
0.73 = 1.21.
9. What are our requirements for an acceptable perimeter? We will
use results from automated static threshold perimetry performed on a
perimeter that:
a. Uses optical projection to generate the test stimuli.
b. Has an internal normative database for automatically comparing
your performance with that of the general population.
c. Has a statistical analysis package that is able to calculate
visual field indices, particularly mean deviation or mean defect.
d. Demonstrates the ability to correctly detect visual field loss
and correctly identify normal visual fields.
e. Demonstrates good test-retest reliability.
f. Has undergone clinical validation studies by three or more
independent laboratories with results published in peer-reviewed
ophthalmic journals.
* * * * *
102.01 Category of Impairments, Special Senses and Speech
102.02 Loss of central visual acuity.
A. Remaining vision in the better eye after best correction is 20/
200 or less.
OR
B. An inability to participate in visual acuity testing using
Snellen methodology or other comparable testing, clinical findings that
fixation and visual-following behavior are absent in the better eye,
and one of the following:
1. Abnormal anatomical findings indicating a visual acuity of 20/
200 or less in the better eye (such as the presence of Stage III or
worse retinopathy of prematurity despite surgery, hypoplasia of the
optic nerve, albinism with macular aplasia, or bilateral optic
atrophy); or
2. Abnormal neuroimaging documenting damage to the cerebral cortex
which would be expected to prevent the development of a visual acuity
better than 20/200 in the better eye (such as neuroimaging showing
bilateral encephalomyelitis or bilateral encephalomalacia); or
3. Abnormal electroretinogram documenting the presence of Leber's
congenital amaurosis or achromatopsia in the better eye; or
4. An absent response to VER testing in the better eye.
102.03 Contraction of the visual field in the better eye, with:
A. The widest diameter subtending an angle around the point of
fixation no greater than 20 degrees.
OR
B. An MD of 22 decibels or greater, determined by automated static
threshold perimetry that measures the central 30 degrees of the visual
field (see 102.00A6d.).
OR
C. A visual field efficiency of 20 percent or less, determined by
kinetic perimetry (see 102.00A7c).
102.04 Loss of visual efficiency, or visual impairment, in the
better eye:
A. A visual efficiency percentage of 20 or less after best
correction (see 102.00A7d.).
OR
B. A visual impairment value of 1.00 or greater after best
correction (see 102.00A8d).
* * * * *
[FR Doc. 2013-06975 Filed 3-27-13; 8:45 am]
BILLING CODE 4191-02-P